IRI,label,variable,displayOrder,dataFile,definition,category,parentIRI,parentLabel,codebookDescription,codebookValues,termType,repeated,is_temporal,mergeKey,dataSet,replaces,unitLabel,unitIRI,is_featured,hidden,scale,defaultDisplayRangeMin,defaultDisplayRangeMax,defaultBinWidth
http://purl.obolibrary.org/obo/PCO_0000024,Household,,,,,Household,http://www.w3.org/2002/07/owl#Thing,,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,yes,,,,
http://purl.obolibrary.org/obo/EUPATH_0036201,Almeria (steel cabinet),ext_bv_ses::almr,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b1. In your dwelling is there Furniture: Almeria,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036205,Bench,ext_bv_ses::bench,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b4. In your dwelling is there Furniture: Bench,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_01000614,Bicycle,ext_bv_ses::bcycl,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b9. In your dwelling is there Furniture:Bi-cycle,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_01000586,Chair,ext_bv_ses::chair,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b3. In your dwelling is there Furniture: Chair,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036207,Cooking gas,ext_bv_ses::gas,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15a2. In your dwelling is there: Cooking Gas,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036208,Cot or bed,ext_bv_ses::bed,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b6. In your dwelling is there Furniture: Cot or Bed,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0021084,Electricity,ext_bv_ses::elec,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15a1. In your dwelling is there: Electricity,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036212,Fan,ext_bv_ses::fan,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b12. In your dwelling is there Furniture: Fan,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_01000615,Motorcycle or scooter,ext_bv_ses::mcycl,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b10. In your dwelling is there Furniture: Motor-cycle,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_01000577,Radio,ext_bv_ses::radio,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b7. In your dwelling is there Furniture: Working radio,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0035003,Sewing machine,ext_bv_ses::sewm,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b11. In your dwelling is there Furniture: Sewing machine,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,EUPATH_0036223,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_01000584,Table,ext_bv_ses::tabl,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b2. In your dwelling is there Furniture: Table,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_01000580,Telephone (mobile or non-mobile),ext_bv_ses::phon,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15a3. In your dwelling is there: Telephone/Mobile,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_01000579,Television,ext_bv_ses::tv,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b8. In your dwelling is there Furniture:Working TV,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036225,Watch or clock,ext_bv_ses::clock,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,15b5. In your dwelling is there Furniture: Watch or Clock,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000006,Floor material,ext_bv_ses::flor,1,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000303,Dwelling characteristics,12. What is the principal type of flooring in your dwelling?,1= Earth; 2= bamboo/Wood; 3= Cement;,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000009,Wall material,ext_bv_ses::wall,2,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000303,Dwelling characteristics,13. What is the principal wall material in your house?,"1= Bamboo/cane/ straw; 2= Rudimentary walls (Mud) or Mixed with mud; 3= Tin; 4= Bricks, cement blocks, concrete walls",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000003,Roof material,ext_bv_ses::roof,3,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000303,Dwelling characteristics,14. What is the principal roofing material in your house?,1= Natural material roofing (straw);  2= Rudimentary roofing (Poly-thene or Mixed with mud);  3= Finished roof; 4= Tin,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000381,Kitchen location,ext_bv_ses::ckpl,4,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000303,Dwelling characteristics,24. Place for cooking for household,"1 = inside house, 2 = separate building; 3 = outdoors; 4 = other",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011593,Room count,ext_bv_ses::room,5,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000303,Dwelling characteristics,4. Number of rooms in current household,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036222,Open drain,ext_bv_ses::drain,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0010032,Dwelling environment,26. Open drain beside your house,1=Yes; 2=No;,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000023,Cooking fuel,ext_bv_ses::fuel,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000302,Dwelling facilities,25. Type of cooking fuel,"1 = Gas, 2 = electric stove; 3 = wood stove; 4= Kerosene oil stove; 5 = Animal dung; 6 = Garments products",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000596,Waste disposal,,,,,Household,http://purl.obolibrary.org/obo/EUPATH_0000302,Dwelling facilities,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036215,Food availabilty,ext_bv_ses::hhfd,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0011683,Food security,"19. In terms of household food availability, how do you classify your household?",1 = Deficit in whole year;  2 = Sometimes deficit;  3 = Neither deficit nor surplus;  4 = Surplus,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_00000009,Country,country,,,,Household,http://purl.obolibrary.org/obo/GAZ_00000448,Geographic location,,,"variable,derived",,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036480,After cleaning infant's anus,ext_bv_ses::hwanu,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036009,Hand washed,20e1. How after cleaning infant's anus,"1 = Left hand, 2 = Right hand, 3 = Both Hands, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036482,After defecating,ext_bv_ses::hwdef,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036009,Hand washed,20c1. How after defecating (self),"1 = Left hand, 2 = Right hand, 3 = Both Hands, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036484,Before cleaning infant's bottle,ext_bv_ses::hwfd,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036009,Hand washed,20d1. How before cleaning infant's bottle,"1 = Left hand, 2 = Right hand, 3 = Both Hands, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036486,Before feeding infant,ext_bv_ses::hwbot,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036009,Hand washed,20a1.How before feeding infant,"1 = Left hand, 2 = Right hand, 3 = Both Hands, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036488,Before feeding self,ext_bv_ses::hweat,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036009,Hand washed,20b1.How before feeding self,"1 = Left hand, 2 = Right hand, 3 = Both Hands, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036199,After cleaning infant's anus,ext_bv_ses::aganu,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0010400,Hand washing material,20e1. Type of Agent after cleaning infant's anus,"1 = Water, 2 = Mud, 3 = Ash, 4 = Soap, 5 = Other, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036200,After defecating,ext_bv_ses::agdef,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0010400,Hand washing material,20c1. Type of Agent after defecating (self),"1 = Water, 2 = Mud, 3 = Ash, 4 = Soap, 5 = Other, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036202,Before cleaning infant's bottle,ext_bv_ses::agbot,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0010400,Hand washing material,20d1. Type of Agent before cleaning infant's bottle,"1 = Water, 2 = Mud, 3 = Ash, 4 = Soap, 5 = Other, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036203,Before feeding infant,ext_bv_ses::agfd,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0010400,Hand washing material,20a1. Type of Agent before feeding infant,"1 = Water, 2 = Mud, 3 = Ash, 4 = Soap, 5 = Other, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036489,Before feeding self,ext_bv_ses::ageat,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0010400,Hand washing material,20b1.Type of Agent before feeding self,"1 = Water, 2 = Mud, 3 = Ash, 4 = Soap, 5 = Other, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036481,After cleaning infant's anus,ext_bv_ses::suran,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036010,Hand washing water source,20e1. Source of Water after cleaning infant's anus,"1 = Municipality supply, 2 = Own Arrangement by plastic pipe, 3 = Tube well,4 = Well/Pond/Canal, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036483,After defecating,ext_bv_ses::surdf,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036010,Hand washing water source,20c1. Source of Water after defecating (self),"1 = Municipality supply, 2 = Own Arrangement by plastic pipe, 3 = Tube well,4 = Well/Pond/Canal, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036485,Before cleaning infant's bottle,ext_bv_ses::surbt,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036010,Hand washing water source,20d1. Source of Water before cleaning infant's bottle,"1 = Municipality supply, 2 = Own Arrangement by plastic pipe, 3 = Tube well,4 = Well/Pond/Canal, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036487,Before feeding infant,ext_bv_ses::surfd,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036010,Hand washing water source,20a1.Source of Water before feeding infant,"1 = Municipality supply, 2 = Own Arrangement by plastic pipe, 3 = Tube well,4 = Well/Pond/Canal, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036204,Before feeding self,ext_bv_ses::suret,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0036010,Hand washing water source,20b1.Source of Water before feeding self,"1 = Municipality supply, 2 = Own Arrangement by plastic pipe, 3 = Tube well,4 = Well/Pond/Canal, 9=None",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011995,Household observation details,,1,,,Household,http://purl.obolibrary.org/obo/PCO_0000024,Household,,,category,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000303,Dwelling characteristics,,2,,,Household,http://purl.obolibrary.org/obo/PCO_0000024,Household,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010032,Dwelling environment,,3,,,Household,http://purl.obolibrary.org/obo/PCO_0000024,Household,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000302,Dwelling facilities,,4,,,Household,http://purl.obolibrary.org/obo/PCO_0000024,Household,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000731,Household water,,5,,,Household,http://purl.obolibrary.org/obo/PCO_0000024,Household,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000686,Hygiene,,6,,,Household,http://purl.obolibrary.org/obo/PCO_0000024,Household,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,,7,,,Household,http://purl.obolibrary.org/obo/PCO_0000024,Household,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/GAZ_00000448,Geographic location,,8,,,Household,http://purl.obolibrary.org/obo/PCO_0000024,Household,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0021085,Household data collection date,ext_bv_ses::dov,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0011995,Household observation details,1. Date of assessment,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ENVO_00003064,Drinking water source,ext_bv_ses::watr,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000731,Household water,17. What is the principal source of household DRINKING WATER?,"1 = Municipality supply/piped water ; 2 = Own arrangement by pump; 3 = Tube well; 4 = Well/Pond/Canal        
surface water",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010108,Drinking water treatment,ext_bv_ses::watrt,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000731,Household water,21. Water treatment methods used,1 = None  2 = Let it stand and settle; 3 = Water filter; 4 = Solar disinfection; 5 = Boil; 6 = Strain through cloth; 7 = Add bleach/ chlorine;,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036009,Hand washed,,,,,Household,http://purl.obolibrary.org/obo/EUPATH_0000686,Hygiene,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010400,Hand washing material,,,,,Household,http://purl.obolibrary.org/obo/EUPATH_0000686,Hygiene,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036010,Hand washing water source,,,,,Household,http://purl.obolibrary.org/obo/EUPATH_0000686,Hygiene,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036219,Maternal nail cutting frequency,ext_bv_ses::nail,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000686,Hygiene,23. Frequency of nail cutting of mother,"1 = Once in a week, 2 = Twice in a month; 3 = Once in a month; 4 = Once in Quarter",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000727,Family income (local currency),ext_bv_ses::inco,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0011680,Income,11a. Total Monthly  Income (in Taka),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000144,Assets,,1,,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036216,Household member listens to or watches radio or TV,ext_bv_ses::mmed,10,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,16b. Do you listen / watch Radio or TV?,1 = Regular;  2 = Irregular ly ; 3 = No,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036217,Household member reads newspaper,ext_bv_ses::news,11,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,16a.  Do you read newspaper?,1 = Regular;  2 = Irregular ly;  3=No,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036209,Domestic workers,ext_bv_ses::dwkr,2,ext_bv_ses,Household has domestic workers (maid).,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,7. Household domestic workers (maid),1=Yes; 2=No;,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000383,Home ownership,ext_bv_ses::hown,3,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,10. Do you own the house you live in?,1=Yes; 2=No;,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011680,Income,,4,,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036210,Family expenditures (local currency),ext_bv_ses::exp,5,ext_bv_ses,"Based on household rent (considered 0 if the family owns the home), expenditures on things like food, cloths, utility bills, and other expenditures like festivals, medical care, education, and gifts.",Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,11b. TotalMonthly Expenditure (in Taka),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011683,Food security,,6,,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036211,Family type,ext_bv_ses::fam,7,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,6. Family Type,1=Nuclear; 2= Joint,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000019,Persons living in house count,ext_bv_ses::hmem,8,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,2. How many members are in your household?,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000714,Persons sleeping in dwelling count,ext_bv_ses::pepl,9,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000304,Socioeconomic factors,5. Number of people usually sleeping in household,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000335,Human waste facilities,ext_bv_ses::toil,,ext_bv_ses,,Household,http://purl.obolibrary.org/obo/EUPATH_0000596,Waste disposal,18. What is the principal type of TOILET facility used by members of your household?,"1 = Septic tank or toilet
2 = Water-sealed or slab latrine
3 = Pit latrine
4 = Open latrine
5 = Hanging latrine
6 = Bush, field as latrine",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036517,Shared human waste facilities,ext_bv_ses::tshar,,ext_bv_ses,Toilet facility shared with other households,Household,http://purl.obolibrary.org/obo/EUPATH_0000596,Waste disposal,22. Toilet facility shared with other households,1=Yes; 2=No,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,,,Participant,http://www.w3.org/2002/07/owl#Thing,,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,yes,,,,
http://purl.obolibrary.org/obo/EUPATH_0036429,Poliovirus vaccine randomization,ext_mgmt_prn::polioarm,1,ext_mgmt_prn,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010035,Administrative information,Randomized to receive IPV vaccine,0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,yes,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036422,Rotarix vaccine randomization,ext_mgmt_bv_mib_st::rotaarm,2,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010035,Administrative information,Randomized to receive rotarix vaccine,0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,yes,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036421,Protocol version at enrollment,ext_mgmt_bv_mib_st::enrptclver,3,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010035,Administrative information,Protocol version at Enrollment,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036427,Polio vaccination per protocol,ext_mgmt_ppg::pp,4,ext_mgmt_ppg,"Whether strictly per protocol as described here. The participant (1) must have received all doses of vaccine as in protocol and according to assigned treatment arm, (2) received‚àö√§no extra vaccinations outside the protocol, (3) received all vaccinations as per vaccination window defined in the protocol, (4) should not have been terminated before the vaccination dose.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010035,Administrative information,whether strictly per protocol as described below under PP set,0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036426,Polio vaccination dose per protocol,ext_mgmt_ppg::ppdose,5,ext_mgmt_ppg,Whether the participant received all intervention doses even if outside the visit window. The justification for relaxing the vaccination window requirement is partially based on the WHO recommendations which emphasize getting the required doses rather than exact ages for receiving the doses and the pragmatic concern of how far outside the window do we set the threshold.‚àö√§,Participant,http://purl.obolibrary.org/obo/EUPATH_0010035,Administrative information,Received all intervention doses even if outside the visit window,0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036428,Received extra OPV,ext_mgmt_ppg::exopv,6,ext_mgmt_ppg,Whether the participant received extra opv doses outside the study during the Bangladesh immunization campaign.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010035,Administrative information,Received extra opv doses outside the study during Bangladesh immunization campaign,0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036471,Rotavirus vaccination per protocol,ext_mgmt_rto2::rotaprotd,7,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010035,Administrative information,Description related to study protocol administered,PP = as randomization; other as described,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036554,Adverse event report date,ext_mgmt_bv_aed_st::aerepdt | ext_bv_sae_st::saedov,1,ext_mgmt_bv_aed_st | ext_bv_sae_st,Collected for adverse events and severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,1. Today's Date | AE report date,09/09/1999=not done,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036559,Associated study procedure,ext_mgmt_bv_aed_st::type,10,ext_mgmt_bv_aed_st,Indicates which study procedure occurred up to 48 hours before the reported adverse event. Not collected for serious adverse events (SAEs).,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,AE type,L/M administration; Phlebotomy; Vaccination,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041169,Serious adverse event,ext_mgmt_bv_aed_st::saeyes | ext_bv_sae_st::saeyes,11,ext_mgmt_bv_aed_st | ext_bv_sae_st,Indicates if the adverse event was considered a serious adverse event.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,4.Did the event result in any of the following: Death; Life-Threatening event; Hospitalization or prolongatin in existing hospitalization; Significant disability or incapacity,1=Yes; 2=No,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036555,Seriousness criteria,ext_bv_sae_st::saevnt,12,ext_bv_sae_st,Only collected for serious adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,"4a.If the answer to # 4 is YES, which event was the final outcome?",1 = Death; 2 = Life-threatening event; 3 = Hospitalization or prolongationof existing hospitalizatio; 4 = Significant disability or incapacity,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036556,Serious adverse event hospitalization date,ext_bv_sae_st::saespdt,13,ext_bv_sae_st,Date hospitalized for severe adverse event (SAE). Only collected for serious adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,4c. Date of hospitalization,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041170,Adverse event duration,aeduration,14,,,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,,,"variable,derived",yes,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041158,Adverse event start date,ext_bv_sae_st::saerdt | ext_mgmt_bv_aed_st::aedt,2,ext_mgmt_bv_aed_st | ext_bv_sae_st,Collected for adverse events and severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,2. Date of earliest symptom(s) onset | AE onset date,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041155,Adverse event name,ext_mgmt_bv_aed_st::category | ext_bv_sae_st::saename,3,ext_mgmt_bv_aed_st | ext_bv_sae_st,Collected for adverse events and severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,4b. Specify the primary illness related to the event | AE Category,"1=Diarrheal illness, 2=Respiratory illness; 3=Febrile illness, 4= Malnutrition, 5=Inguinal hernia, 6= Convulsion, 7=Cyanosis, 8= Lethargy, 9= Sepsis,10 = Vomiting, 11=Respiratory distress, 88= other | Diarrhea; Fever; Redness; Stools; Swelling; Vomiting",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036569,"Adverse event name, other",ext_bv_sae_st::saespec,4,ext_bv_sae_st,Only collected for severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,"4b1. If the answer to question 4b is other (88), please specify",,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041157,Adverse event severity,ext_mgmt_bv_aed_st::severity | ext_bv_sae_st::saegrd,5,ext_mgmt_bv_aed_st | ext_bv_sae_st,Collected for adverse events and severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,5a. Severity of symptoms | Severity of AE,"1 = Mild, 2 = Moderate; 3= severe | 1 = Mild; 2 = Moderate; 3 = Severe",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041168,Relationship to study intervention,ext_mgmt_bv_aed_st::relation | ext_bv_sae_st::saerlt,6,ext_mgmt_bv_aed_st | ext_bv_sae_st,Collected for adverse events and severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,Relationship to intervention | 5b. Relationship to study interventions,1=  Definitely; 2= Possibly; 3= Unrelated | 1 = Definitely related; 2 = Possibly related; 3 = Unrelated,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036557,Action taken,ext_mgmt_bv_aed_st::action | ext_bv_sae_st::saeact,7,ext_mgmt_bv_aed_st | ext_bv_sae_st,Collected for adverse events and severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,Action taken | 5c. Actions,"1 = None; 2 = Remedial therapy; 3 = Discontinuation 4= Hospitalization
5 = Other | 1 = None; 2 = Remedial therapy; 3 = Permanently discontinued from study participation
4 = Hospitalization
5 = Other",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041156,Adverse event outcome,ext_bv_sae_st::saeotc | ext_mgmt_bv_aed_st::outcome,8,ext_mgmt_bv_aed_st | ext_bv_sae_st,Collected for adverse events and severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,Outcome of AE | 5d. Outcome,"1 = Resolved; 2 = Continuing; 3 = Death;  4= Unknown/Lost to FU | 1 = Resolved ; 2 = Continuing, do not anticipate resolution; 3 = Death; 4 = Unknown/ lost to follow up",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041154,Adverse event end date,ext_bv_sae_st::saersdt | ext_mgmt_bv_aed_st::aeresdt,9,ext_mgmt_bv_aed_st | ext_bv_sae_st,Collected for adverse events and severe adverse events.,Participant,http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,AE resolution date | 6. Date of SAE resolution,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036461,Any rotavirus-associated diarrhea,ext_mgmt_rto2::rotaepi,1,ext_mgmt_rto2,Did the child have at least one episode of rotavirus associated diarrhea (trial endpoint).,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Did the child have at least one episode of rotavirus associated diarrhea (trial endpoint),0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036468,Median Vesikari score per diarrheal episode,ext_mgmt_rto2::mdvrsepi,10,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Median VR Score per episode,NA=not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036464,Maximum Vesikari score per diarrheal episode,ext_mgmt_rto2::maxvrsepi,11,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Maximum VR Score per episode,NA=not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036466,Mean Vesikari score per diarrheal episode,ext_mgmt_rto2::mnvrsepi,12,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Mean VR score per episode,NA=not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036478,Vesikari score per diarrheal episode standard deviation,ext_mgmt_rto2::sdvrsepi,13,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Std.deviation VR Score per episode,NA=not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010477,Total diarrheal episodes,ext_mgmt_rto2::nepi,14,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Number of episodes in infants during first 2 years of life,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036474,Total rotavirus-associated diarrheal episodes,ext_mgmt_rto2::nrtepi,15,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Number of Rota associated episodes (lab_bv_rota.rotads=1),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036473,Total diarrheal episodes without rotavirus status,ext_mgmt_rto2::nmissrtepi,16,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Number of episodes missing Rota determination (no specimen),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036475,Total severe diarrheal episodes,ext_mgmt_rto2::nsvepi,17,ext_mgmt_rto2,Vesikari score >= 11,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Number of severe episodes (VR Score >= 11),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036477,Total severe rotavirus-associated diarrheal episodes,ext_mgmt_rto2::nsvrtepi,18,ext_mgmt_rto2,Vesikari score >= 11,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Number of severe (VR Score >= 11) Rota associated episodes,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036476,Total severe diarrheal episodes without rotavirus status,ext_mgmt_rto2::nmissrtsvepi,19,ext_mgmt_rto2,Vesikari score >= 11,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Number of missing rotavirus determinations (episodes) conditional on an episode having a non-missing VRS and VRS >= 11(Ruuska score) during first 365 days,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036340,"Rotavirus P genotype, first diarrheal episode",ext_lab_bv_rptype::ptype1,2,ext_lab_bv_rptype,Rotavirus P-type by sequencing for the first rotavirus-positive diarrheal episode stool in year 1.,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,"Rotavirus P-type by sequencing, first rota+ diarrheal episode stool in year 1","0=Sequenced but could not be typed, 77=Not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000742,Total time in all diarrheal episodes,ext_mgmt_rto2::totdurdia,20,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Total duration of diarrhea (sum of episode duration),,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036472,Total time in all severe diarrheal episodes,ext_mgmt_rto2::totdursvdia,21,ext_mgmt_rto2,Vesikari score >= 11,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Total duration of severe diarrhea (sum of severe episode duration),,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036341,"Rotavirus P genotype, second diarrheal episode",ext_lab_bv_rptype::ptype2,3,ext_lab_bv_rptype,Rotavirus P-type by sequencing for the second rotavirus-positive diarrheal episode stool in year 1.,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,"Rotavirus P-type by sequencing, second rota+ diarrheal episode in year 1","0=Sequneced but could not be typed, 77=Not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036469,Minimum diarrheal episode duration,ext_mgmt_rto2::mindurepi,4,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Minimum duration of episode,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036467,Median diarrheal episode duration,ext_mgmt_rto2::mddurepi,5,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Median duration of episode,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036463,Maximum diarrheal episode duration,ext_mgmt_rto2::maxdurepi,6,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Maximum duration of episode,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036465,Mean diarrheal episode duration,ext_mgmt_rto2::mndurepi,7,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Mean duration of episode,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036462,Diarrheal episode duration standard deviation,ext_mgmt_rto2::sddurepi,8,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Std.deviation of duration of episode,NA=not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036470,Minimum Vesikari score per diarrheal episode,ext_mgmt_rto2::minvrsepi,9,ext_mgmt_rto2,,Participant,http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,Minimum VR Score per episode,NA=not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036446,Polio serotype 1 seroconversion failure,ext_mgmt_pso_st::scon40fs1,9,ext_mgmt_pso_st,Seroconversion failure was derived based on the child's serum neutralizing antibodies (SNA) at 40 weeks (SNAwk40) and the maternal-antibody adjusted SNA at 18 weeks (SNAwk18). The participant was considered to have failed to seroconvert if a) SNAwk18 ¬¨‚â§ 2.833 and SNAwk40 ¬¨‚â§ 3 or b)  2.833< SNAwk18 ¬¨‚â§ 8.5 and (SNAwk40 - SNAwk18) < 2 or c) 8.5 < SNAwk18 <10.5 and SNAwk40 < 10.5. Participants with SNAwk18  ¬¨‚â• 10.5 were excluded.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Sabin 1 seroconversion failure * 1.For subjects 2.833< SNAwk18_adjust ¬¨‚â§ 8.5
Seroconversion failure if (SNAwk40 - SNAwk18_adjust)<2
2.For subjects 8.5 < SNAwk18_adjust <10.5 
   Seroconversion failure if SNAwk40 < 10.5
3. For subjects SNAwk18_adjust ¬¨‚â§ 2.833
   Seroconversion failure if SNAwk40 ¬¨‚â§ 3
4. For subjects SNAwk18_adjust¬¨‚â•10.5, excluded.",0=No; 1=yes; NA,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036447,Polio serotype 2 seroconversion failure,ext_mgmt_pso_st::scon40fs2,10,ext_mgmt_pso_st,Seroconversion failure was derived based on the child's serum neutralizing antibodies (SNA) at 40 weeks (SNAwk40) and the maternal-antibody adjusted SNA at 18 weeks (SNAwk18). The participant was considered to have failed to seroconvert if a) SNAwk18 ¬¨‚â§ 2.833 and SNAwk40 ¬¨‚â§ 3 or b)  2.833< SNAwk18 ¬¨‚â§ 8.5 and (SNAwk40 - SNAwk18) < 2 or c) 8.5 < SNAwk18 <10.5 and SNAwk40 < 10.5. Participants with SNAwk18  ¬¨‚â• 10.5 were excluded.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Sabin 2 seroconversion failure * 1.For subjects 2.833< SNAwk18_adjust ¬¨‚â§ 8.5
Seroconversion failure if (SNAwk40 - SNAwk18_adjust)<2
2.For subjects 8.5 < SNAwk18_adjust <10.5 
   Seroconversion failure if SNAwk40 < 10.5
3. For subjects SNAwk18_adjust ¬¨‚â§ 2.833
   Seroconversion failure if SNAwk40 ¬¨‚â§ 3
4. For subjects SNAwk18_adjust¬¨‚â•10.5, excluded.",0=No; 1=yes; NA,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036448,Polio serotype 3 seroconversion failure,ext_mgmt_pso_st::scon40fs3,11,ext_mgmt_pso_st,Seroconversion failure was derived based on the child's serum neutralizing antibodies (SNA) at 40 weeks (SNAwk40) and the maternal-antibody adjusted SNA at 18 weeks (SNAwk18). The participant was considered to have failed to seroconvert if a) SNAwk18 ¬¨‚â§ 2.833 and SNAwk40 ¬¨‚â§ 3 or b)  2.833< SNAwk18 ¬¨‚â§ 8.5 and (SNAwk40 - SNAwk18) < 2 or c) 8.5 < SNAwk18 <10.5 and SNAwk40 < 10.5. Participants with SNAwk18  ¬¨‚â• 10.5 were excluded.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Sabin 3 seroconversion failure * 1.For subjects 2.833< SNAwk18_adjust ¬¨‚â§ 8.5
Seroconversion failure if (SNAwk40 - SNAwk18_adjust)<2
2.For subjects 8.5 < SNAwk18_adjust <10.5 
   Seroconversion failure if SNAwk40 < 10.5
3. For subjects SNAwk18_adjust ¬¨‚â§ 2.833
   Seroconversion failure if SNAwk40 ¬¨‚â§ 3
4. For subjects SNAwk18_adjust¬¨‚â•10.5, excluded.",0=No; 1=yes; NA,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036449,Shed poliovirus at 14 weeks,ext_mgmt_pto::anyc14,12,ext_mgmt_pto,"Any week 14 stools (day 0, 4, 11, 18, or 25) positive for polio by culture.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Derived column for Polio pcr positive in any week 14 shedding stool (day 0,4,11,18,or 25)",0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036450,Shed poliovirus at 52 weeks,ext_mgmt_pto::anyc52,13,ext_mgmt_pto,"Any week 52 stools (day 0, 4, 11, 18, or 25) positive for polio by culture. Primary endpoint variable. Any child that did not make the week 52 visit is coded as ""No"".",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Derived column for Polio pcr positive in any week 14 shedding stool (day 0,4,11,18,or 25). Being  primary endpoint variables, kids that didn't make wk52 visit are coded 0=no",0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036451,"Shed poliovirus at 52 weeks, by qRT-PCR",ext_mgmt_pto::anyq52,14,ext_mgmt_pto,"Any week 52 stools (day 0, 4, 11, 18, or 25) positive for polio by multiplexed qRT-PCR.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,Any qpcr shedding at week 52,"0=No; 1=Yes, Na=not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036452,Shed poliovirus serotype 1 at 14 weeks,ext_mgmt_pto::anyc14s1,15,ext_mgmt_pto,"Any week 14 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 1 by culture and rRT-PCR.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Derived column for Sabin 1 positive in any (day 0,4,11,18,or 25) week 14 shedding stool",0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036453,Shed poliovirus serotype 1 at 52 weeks,ext_mgmt_pto::anyc52s1,16,ext_mgmt_pto,"Any week 52 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 1 by culture and rRT-PCR. Primary endpoint variable. Any child that did not make the week 52 visit is coded as ""No"".",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Derived column for Sabin 1 positive in any (day 0,4,11,18,or 25) week 14 shedding stool. Being  primary endpoint variables, kids that didn't make wk52 visit are coded 0=no",0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036454,"Shed poliovirus serotype 1 at 52 weeks, by qRT-PCR",ext_mgmt_pto::anyq52s1,17,ext_mgmt_pto,"Any week 52 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 1 by multiplexed qRT-PCR.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,Any qpcr sabin 1 shedding at week 52,"0=No; 1=Yes, Na=not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036455,Shed poliovirus serotype 2 at 14 weeks,ext_mgmt_pto::anyc14s2,18,ext_mgmt_pto,"Any week 14 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 2 by culture and rRT-PCR.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Derived column for Sabin 2 positive in any (day 0,4,11,18,or 25) week 14 shedding stool",0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036456,Shed poliovirus serotype 2 at 52 weeks,ext_mgmt_pto::anyc52s2,19,ext_mgmt_pto,"Any week 52 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 2 by culture and rRT-PCR. Primary endpoint variable. Any child that did not make the week 52 visit is coded as ""No"".",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Derived column for Sabin 2 positive in any (day 0,4,11,18,or 25) week 14 shedding stool. Being  primary endpoint variables, kids that didn't make wk52 visit are coded 0=no",0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036457,"Shed poliovirus serotype 2 at 52 weeks, by qRT-PCR",ext_mgmt_pto::anyq52s2,20,ext_mgmt_pto,"Any week 52 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 2 by multiplexed qRT-PCR.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,Any qpcr sabin 2 shedding at week 52,"0=No; 1=Yes, Na=not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036458,Shed poliovirus serotype 3 at 14 weeks,ext_mgmt_pto::anyc14s3,21,ext_mgmt_pto,"Any week 14 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 3 by culture and rRT-PCR.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Derived column for Sabin 3 positive in any (day 0,4,11,18,or 25) week 14 shedding stool",0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036459,Shed poliovirus serotype 3 at 52 weeks,ext_mgmt_pto::anyc52s3,22,ext_mgmt_pto,"Any week 52 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 3 by culture and rRT-PCR. Primary endpoint variable. Any child that did not make the week 52 visit is coded as ""No"".",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,"Derived column for Sabin 3 positive in any (day 0,4,11,18,or 25) week 14 shedding stool. Being  primary endpoint variables, kids that didn't make wk52 visit are coded 0=no",0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036460,"Shed poliovirus serotype 3 at 52 weeks, by qRT-PCR",ext_mgmt_pto::anyq52s3,23,ext_mgmt_pto,"Any week 52 stools (day 0, 4, 11, 18, or 25) positive for polio serotype Sabin 3 by multiplexed qRT-PCR.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,Any qpcr sabin 3 shedding at week 52,"0=No; 1=Yes, Na=not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000105,BMI,ext_mgmt_bv_danth::bmi,1,ext_mgmt_bv_danth,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000649,Anthropometry,BMI derived (Wt in Kg/Ht in meter 2,,variable,yes,,,PROVIDE Randomized Controlled Trial,EUPATH_0000661,kg/m2,http://purl.obolibrary.org/obo/UO_0000086,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010075,Height,ext_mgmt_bv_danth::htcm | ext_bv_sbo::sbht,2,ext_mgmt_bv_danth | ext_bv_sbo,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000649,Anthropometry,3b. Length of baby in Cm | 8. Length of the baby in cm,999.9 = missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,cm,http://purl.obolibrary.org/obo/UO_0000015,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011894,Height-for-age z-score,ext_mgmt_bv_danth::haz,3,ext_mgmt_bv_danth,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000649,Anthropometry,Height for age assessed using MGRS application,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/IAO_0000414,Weight,ext_bv_dep_st::dewt | ext_mgmt_bv_danth::wtkg | ext_bv_sbo::sbwt,4,ext_mgmt_bv_danth | ext_bv_dep_st | ext_bv_sbo,Assessed during diarrheal episodes and at each visit week.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000649,Anthropometry,3.  Weight of the baby today in Kg | Weight of the baby in Kg | 3a. Weight of the baby in Kg,99.9 = missing | 99.99 = missing,variable,yes,,,PROVIDE Randomized Controlled Trial,EUPATH_0000732,kg,http://purl.obolibrary.org/obo/UO_0000009,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000733,Weight-for-age z-score,ext_mgmt_bv_danth::waz,5,ext_mgmt_bv_danth,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000649,Anthropometry,Weight for age assessed using MGRS application,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011895,Weight-for-height z-score,ext_mgmt_bv_danth::whz,6,ext_mgmt_bv_danth,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000649,Anthropometry,weight for height assessed using MGRS application,NA=Not Available/Not applicable,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036198,Weight-for-age or weight-for-height z-score below -3,ext_bv_sbo::sbmal,7,ext_bv_sbo,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000649,Anthropometry,3c. Is the child's WAZ or WHZ <-3 SD?,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000582,"Antibiotics, caregiver report",ext_bv_dir_st::antbi,,ext_bv_dir_st,"If diarrhea reported, assessed for each day of diarrheal episode.",Participant,http://purl.obolibrary.org/obo/EUPATH_0011880,Antibiotic administration,Child on antibiotics,1=Yes; 2=No; 99=not available/done,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036103,Bayley scales assessment date,ext_bv_f104::f104bydt | ext_bv_fan::fanbaydt,1,ext_bv_f104 | ext_bv_fan,Completed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,7a.1. Date of assessment of  Bayley Scales of Infant and Toddler Development | 8a1. Date of assessment of Bayley,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036042,Language scaled sum,ext_bv_bsc::langscal,10,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,5e. Language  scaled sum,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036041,Language composite score,ext_bv_bsc::langcmp,11,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,5f. Language composite score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036037,Fine motor raw score,ext_bv_bsc::fmotoraw,12,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,6a. Fine motor raw score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036038,Fine motor scaled score,ext_bv_bsc::fmotoscal,13,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,6b. Fine motor scaled score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036039,Gross motor raw score,ext_bv_bsc::gmotoraw,14,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,6c. Gross motor raw score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036040,Gross motor scaled score,ext_bv_bsc::gmotoscal,15,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,6d. Gross motor scaled score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036044,Motor scaled sum,ext_bv_bsc::motoscal,16,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,6e. Motor scaled sum,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036043,Motor composite score,ext_bv_bsc::motocmp,17,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,6f. Motor composite score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036048,Social-emotional raw score,ext_bv_bsc::soemoraw,18,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,7a. Social-Emotional raw score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036049,Social-emotional scaled score,ext_bv_bsc::soemoscal,19,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,7b. Social-Emotional scaled score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036104,Bayley scales of infant and toddler development completed,ext_bv_fan::fanbayl | ext_bv_f104::f104bay,2,ext_bv_f104 | ext_bv_fan,Completed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,8a. Bayley Scales of Infant and Toddler Development | 7a. Bayley Scales of Infant and Toddler      Development,"1=Yes; 2=No; 8 = Refused V7 consent;
9 = Missing | 1=Yes; 2=No; 8=Refused V7 consent;
9 = Missing",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036047,Social-emotional composite score,ext_bv_bsc::soemocmp,20,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,7c. Social-Emotional composite score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036033,Cognitive raw score,ext_bv_bsc::cograw,3,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,4a. Cognitive raw score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036034,Cognitive scaled score,ext_bv_bsc::cogscale,4,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,4b. Cognitive scaled score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036032,Cognitive composite score,ext_bv_bsc::cogcmp,5,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,4c. Cognitive composite score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036045,Receptive communication raw score,ext_bv_bsc::larcraw,6,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,5a. Receptive communication raw score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036046,Receptive communication scaled score,ext_bv_bsc::larcscal,7,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,5b. Receptive communication scaled score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036035,Expressive communication raw score,ext_bv_bsc::laexpraw,8,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,5c. Expressive communication raw score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036036,Expressive communication scaled score,ext_bv_bsc::laexpscal,9,ext_bv_bsc,Assessed at 78 and 104 weeks,Participant,http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,5d. Expressive communication scaled score,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036054,Infant food type,ext_bv_dir_st::bfh,,ext_bv_dir_st,Assessed for each day.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000678,Feeding,Baby Feeding (BF) History *,"1=BM, 2=TM, 3=BM+TM, 4=BM + Other, 5=Non BM, 6=No milk, 99=not available/done",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011014,Cumulative time exclusively breastfed,ext_mgmt_bv_ddep_st::epiexlbf | ext_mgmt_bv_danth::vstexlbf,,ext_mgmt_bv_danth | ext_mgmt_bv_ddep_st,Assessed at each week of observation and prior to each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0011730,Breastfeeding,Number of exclusive breastfeeding days prior to the episode | Number of exclusive breastfeeding days at that visit,,variable,yes,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011049,Age last exclusively breastfed,ext_mgmt_bv_dinf::exlbf1,,ext_mgmt_bv_dinf,,Participant,http://purl.obolibrary.org/obo/EUPATH_0011730,Breastfeeding,Maximum number of days of contiguous exclusive breastfeeding starting from day 1 (Calculated by using minimum date when baby was first introduced to Top feed or mixed feeding.),,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0033152,Breastfeeding duration,ext_mgmt_bv_dinf::anybf,,ext_mgmt_bv_dinf,Number of days of breastfeeding with or without other food sources.,Participant,http://purl.obolibrary.org/obo/EUPATH_0011690,Breastfeeding summary,Number of days of any breast feeding (Includes exclusive BF as well),,variable,,,,PROVIDE Randomized Controlled Trial,EUPATH_0036396,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0042002,Obstetrics,,,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0035113,Multiple birth,ext_bv_enm::dltyp,1,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0042002,Obstetrics,Was current delivery,"1=Single,  2=Twin",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0035114,Birth order,ext_bv_ses::bodr,2,ext_bv_ses,Birth order of enrolled child.,Participant,http://purl.obolibrary.org/obo/EUPATH_0042002,Obstetrics,2b. Birth order of enrolled child,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036567,Mode of birth,ext_bv_enm::delst,3,ext_bv_enm,How participant was delivered,Participant,http://purl.obolibrary.org/obo/EUPATH_0042002,Obstetrics,Current delivery status,"1 = Vaginal,  2 =Caesarian  
3 = Other",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,,4,,,Participant,http://purl.obolibrary.org/obo/OGMS_0000015,Clinical history,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036406,Bacille Calmette-Guerin (BCG) at birth,ext_mgmt_bv_mib_st::bcg,5,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/OGMS_0000015,Clinical history,BCG given at birth,1=Yes; 2=No,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://www.ebi.ac.uk/efo/EFO_0004950,Birth date,ext_mgmt_bv_mib_st::dob,,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010981,Demographics,1. Date of Birth,9/9/99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,yes,,,,
,Birth location,ext_mgmt_bv_mib_st::bpl,,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010981,Demographics,Place of Birth,1= Home; 2= Health facility,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/PATO_0000047,Sex,ext_mgmt_bv_mib_st::sex,,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010981,Demographics,Gender,1= Male; 2=Female,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036195,Small intestine bacterial overgrowth,ext_bv_sbo::sboyes,,ext_bv_sbo,SIBO present (>12 ppm increase in H2 over baseline value on any subsequent value). Assessed at 104 weeks.,Participant,http://purl.obolibrary.org/obo/OGMS_0000073,Diagnosis,6a. SIBO present (>12 ppm increase in H2 over baseline value on any subsequent value),1= Yes; 2= No;9=Not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031286,Vesikari score integer,ext_mgmt_bv_ddep_st::ruuska,,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0011750,Diarrheal episode severity,"Peak score (A+ B + C + D + E + F + G) per episode/ updated from 21 point to 20 point score; Ref: Scand J Infec Dis 22: 259-267, 1990",-9 = Missing',variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010478,Cumulative diarrheal episode count,ext_mgmt_bv_danth::cumepisd,1,ext_mgmt_bv_danth,Cumulative number of diarrheal episodes at each study visit.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,Cummulative episode # up to that visit,-9 = Missing',variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031299,Diarrhea onset date,ext_mgmt_bv_ddep_st::epidate | ext_bv_dep_st::dedt,2,ext_mgmt_bv_ddep_st | ext_bv_dep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,Date Entered | Date of onset of each diarrheal episode,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010472,Diarrheal episode #,ext_mgmt_bv_ddep_st::epinum,3,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,Diarrheal stool episode # assigned in sequence to each episode,"0 =Infant had no episode, 1= first episode, 2= second episode and so on",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010238,Diarrheal episode duration,ext_mgmt_bv_ddep_st::epidays,4,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,Duration of each diarrheal episode,,variable,yes,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010240,Max loose stools at episode count,ext_mgmt_bv_ddep_st::episevrt,5,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,Severity of Diarrhea during each episode (# of diarrheal stool/24 hours),,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031319,Vesikari max loose stools,ext_mgmt_bv_ddep_st::mxdrnosc,6,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,Score assigned to variable Severity of diarrhea to derive RUUSKA : B,"1 = 1-3 ; 2 = 4 - 5,3 = >=6",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011750,Diarrheal episode severity,,7,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010537,Diarrheal stool collected at visit,ext_bv_dir_st::stspc,8,ext_bv_dir_st,"If diarrhea reported, assessed for each day of diarrheal episode.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,Stool collected for this episode,1=Yes; 2=No; 99=not available/done,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036105,Edinburgh Postnatal Depression Scale assessment date,ext_bv_f104::f104epdt,1,ext_bv_f104,Completed at 104 weeks.,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,8c1. Date of assessment of EPD,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036092,Felt sad or miserable in the past 7 days,ext_bv_epd::sad,10,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,10. In the past 7 days have you felt sad or miserable?,"3 = Yes, most of the time
2 = Yes, quite often
1 = Not very often
0 = No, not at all;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036098,So unhappy that you have been crying in the past 7 days,ext_bv_epd::crying,11,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,11. In the past 7 days were you so unhappy that you have been crying?,"3 = Yes, most of the time
2 = Yes, quite often
1 = Only occasionally
0 = No, never;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036099,Thoughts of harming yourself occurred in the past 7 days,ext_bv_epd::selfharm,12,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,12. In the past 7 days have thoughts of harming yourself occurred?,"3 = Yes, quite often 
2 = Sometimes
1 = Hardly ever
0 = Never;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036091,Edinburgh Postnatal Depression Scale score,ext_bv_epd::epdscore,13,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,13. TOTAL SCORE {LAUGH}+{ENJOYMNT}+{ANXIOUS}+{BLAMED}+{SCARED}+{GETTOP}+{DIFFSLEEP}+{SAD}+{CRYING}+{SELFHARM}+{EPDSCORE},99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036097,Mother referred for evaluation,ext_bv_epd::refered,14,ext_bv_epd,"Based on the Edinburgh Postnatal Depression score, was the participant's mother referred for further evaluation.",Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,14. Was the mother referred for further evaluation?,"1 = Yes;  2 = No;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036106,Edinburgh Postnatal Depression Scale completed,ext_bv_f104::f104edp,2,ext_bv_f104,Completed at 104 weeks.,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,8c. Mother Edinburgh Postnatal      Depression Assessment,"1=Yes; 2=No; 8 = Refused V7 consent;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036088,Able to laugh and see the funny side of things in the past 7 days,ext_bv_epd::laugh,3,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,3. In the past 7 days have you been able to laugh and see the funny side of things?,"0 = As much as I always could; 
1 = Not quite so much now;     
2 = Definitely not so much now;
3 = Not at all;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036096,Looked forward with enjoyment to things in the past 7 days,ext_bv_epd::enjoymnt,4,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,4. In the past 7 days have you looked forward with enjoyment to things?,"0 = As much as I ever did
1 = Rather less than I used to    
2 = Definitely less than I used to
3 = Hardly at all;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036089,Anxious or worried for no good reason in the past 7 days,ext_bv_epd::anxious,5,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,5. In the past 7 days have you been anxious or worried for no good reason?,"0 = No, not at all
1 = Hardly ever;                
2 = Yes, sometimes; 
3 = Yes, very often;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036090,Blamed yourself unnecessarily when things went wrong in the past 7 days,ext_bv_epd::blamed,6,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,6. In the past 7 days have you blamed yourself unnecessarily when things went wrong?,"3 = Yes, most of the time
2 = Yes, some of the time
1 = Not very often
0 = No, never;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036093,Felt scared or panicky for no good reason in the past 7 days,ext_bv_epd::scared,7,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,7. In the past 7 days have you felt scared or panicky for no good reason?,"3 = Yes, quite a lot
2 = Yes, sometimes
1 = No, not much
0 = No, not at all;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036095,Felt that things have been getting on top of you in the past 7 days,ext_bv_epd::gettop,8,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,8. In the past 7 days have you felt that things have been getting on top of you?,"3 = Yes, most of the time I haven<U+2019>t been able to cope at all; 2 = Yes, sometimes I haven<U+2019>t been coping as well as usual; 1 = No, most of the time I have coped quite well
0 = No, I have been coping as well as ever;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036094,Felt so unhappy that you had difficulty sleeping in the past 7 days,ext_bv_epd::diffsleep,9,ext_bv_epd,The participant's mother was assessed once during the study,Participant,http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,9. In the past 7 days have you felt so unhappy that you had difficulty sleeping?,"3 = Yes, most of the time
2 = Yes, sometimes
1 = Not very often
0 = No, not at all;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036107,Family care indicators assessment date,ext_bv_fan::fancidt | ext_bv_f104::f104fcdt,1,ext_bv_f104 | ext_bv_fan,Completed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,8b1. Date of assessment of FCI,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036128,Mother read with child,ext_bv_fci::readmthr,10,ext_bv_fci,"Mother read books or looked at picture books, photos, or posters with the child in the last 3 days. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5a.1. Who engaged in reading activity; Mother,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036122,Father read with child,ext_bv_fci::readfthr,11,ext_bv_fci,"Father read books or looked at picture books, photos, or posters with the child in the last 3 days. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5a.2. Who engaged in reading activity; Father,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036132,Other adult read with child,ext_bv_fci::readadlt,12,ext_bv_fci,"Another adult or household member > 15 years old read books or looked at picture books, photos, or posters with the child in the last 3 days. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"5a.3. Who engaged in reading activity; Other adult, household member > 15 years old","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036141,Told child stories,ext_bv_fci::toldstory,13,ext_bv_fci,Someone told stories to the child in the last 3 days. Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5b. Told stories to (child<U+2019>s name)?,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036130,Mother told child stories,ext_bv_fci::storymthr,14,ext_bv_fci,Mother told stories to the child in the last 3 days. Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5b.1. Who engaged in story telling activity with ; Mother,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036124,Father told child stories,ext_bv_fci::storyfthr,15,ext_bv_fci,Father told stories to the child in the last 3 days. Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5d.2. Who engaged in story telling activity with ;Father,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036134,Other adult told child stories,ext_bv_fci::storyadlt,16,ext_bv_fci,Another adult or household member > 15 years old told stories to the child in the last 3 days. Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"5d.3. Who engaged in story telling activity with; Other adult, household member > 15 years old","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036137,Sang with child,ext_bv_fci::sangsong,17,ext_bv_fci,Someone sang to or with the child in the last 3 days. Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"5c. Sangsongs to or with (Child's name), including lullabies","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036129,Mother sang with child,ext_bv_fci::sangmthr,18,ext_bv_fci,Mother sang to or with the child in the last 3 days. Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5c.1. Who engaged in the activity with ; Mother,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036123,Father sang with child,ext_bv_fci::sangfthr,19,ext_bv_fci,Father sang to or with the child in the last 3 days. Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5c.2. Who engaged in the activity with ;Father,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036108,Family care indicators completed,ext_bv_f104::f104fci | ext_bv_fan::fanfci,2,ext_bv_f104 | ext_bv_fan,Completed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,8b. Family Care Indicator,"1=Yes; 2=No; 8 = Refused V7 consent;
9 = Missing",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036133,Other adult sang with child,ext_bv_fci::sangadlt,20,ext_bv_fci,Another adult or household member > 15 years old sang to or with the child in the last 3 days. Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"5c.3. Who engaged in the activity with; Other adult, household member > 15 years old","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036142,Took child outside home,ext_bv_fci::tookout,21,ext_bv_fci,"Someone took the child outside the home, compound, yard, or enclosure in the last 3 days. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"5d.Took (child<U+2019>s name) outside the home, compound, yard, or enclosure?","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036131,Mother took child outside home,ext_bv_fci::tookmthr,22,ext_bv_fci,"Mother took the child outside the home, compound, yard, or enclosure in the last 3 days. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5d.1.  Who engaged in this activity;  Mother,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036125,Father took child outside home,ext_bv_fci::tookfthr,23,ext_bv_fci,"Father took the child outside the home, compound, yard, or enclosure in the last 3 days. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,5d.2.Who engaged in this activity;   Father,"0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036135,Other adult took child outside home,ext_bv_fci::tookadlt,24,ext_bv_fci,"Another adult or household member > 15 years old took the child outside the home, compound, yard, or enclosure in the last 3 days. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"5d.3. Who engaged in this activity;  Other adult, household member > 15 years old","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036121,Family care indicators score,ext_bv_fci::fcitotscr,25,ext_bv_fci,Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,6. TOTAL SCORE {PLAYTOY}+{PLAYMUSC}+{PLAYDRAW}+{PLAYPRTE}+{HHBOOKS}+{HHMAGZIN}+{READBOOK}+{READMTHR}+}READFTHR}+{READADLT}+{TOLDSTOR}+{STORYMTHR}+{STORYFTHR}+{STORYADLT}+{TOOKOUT}+{TOOKMTHR}+{TOOKFTHR}+{TOOKADLT},,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036127,Manufactured toys,ext_bv_fci::playtoy,3,ext_bv_fci,"Toys from a shop or manufactured toys, for example, balls, dolls, cars, or other manufactured toys. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"3a. Toys from a shop or manufactured toys, for example, balls, dolls, cars, or other manufactured toys","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036140,Things that play or make music,ext_bv_fci::playmusc,4,ext_bv_fci,"Things which play music or that you use to make music, for example, plastic toy phones for children, toy radio, dolls that sing, drum. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"3b.Things which play music or that you use to make music, for example, plastic toy phones for children, toy radio, dolls that sing, drum","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036138,Things for drawing or writing,ext_bv_fci::playdraw,5,ext_bv_fci,"Things for drawing or writing, for example, pencils, pens, chalk. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"3c.Things for drawing or writing, for example, pencils, pens, chalk","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036139,Things for pretending,ext_bv_fci::playprte,6,ext_bv_fci,"Things for pretending, for example, dolls to play house, tins to pretend to cook. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"3d. Things for pretending, for example, dolls to play house, tins to pretend to cook","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036120,Books in home count,ext_bv_fci::hhbooks,7,ext_bv_fci,Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,4a. How many books do you have in your home right now?,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036126,Magazines and newspapers in home count,ext_bv_fci::hhmagzin,8,ext_bv_fci,Assessed at 78 and 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,4b. How many magazines and newspapers do you have in your home right now?,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036136,Read with child,ext_bv_fci::readbook,9,ext_bv_fci,"Someone read books or looked at picture books, photos, or posters with the child in the last 3 days. Assessed at 78 and 104 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,"5a. Read books or looked at picture books, photos, or posters with?","0 = No, 1 = Yes",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036412,Food since birth,ext_mgmt_bv_mib_st::food,,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000678,Feeding,Food since birth,1 = Breast Milk(BM); 2=Top Milk (TM); 3 = BM+ TM; 4 = Water/ Sugar or Water/ Honey,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036413,Gestational age assessment date,ext_mgmt_bv_mib_st::gadt,1,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,1. Date of assessment,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036418,Plantar creases,ext_mgmt_bv_mib_st::gaplan,10,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,10. Plantar creases,"1 = Heel-toe <40 mm (-2 points); 2 = Heel-toe 40-50 mm (-1 point); 3 = Heel-toe >50 mm, no creases (0 points); 4 = Faint red marks (1 point); 5 = Anterior transverse crease only (2 points); 6 = Creases over anterior 2/3 (3 points); 7 = Creases over entire sole (4 points);
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036408,Breast,ext_mgmt_bv_mib_st::gabrest,11,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,11. Breast,"1 = Imperceptible (-1 point); 2 = Barely perceptible (0 points); 3 = Flat areola, no bud (1 point); 4 = Stippled areola, 1-2 mm bud (2 points); 5 = Raised areola, 3-4 mm bud (3 points); 6 = Full areola, 5-10 mm bud (4 points);
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036410,Eye and ear,ext_mgmt_bv_mib_st::gaeye,12,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,Eye to Ear,"1 = Lids fused, tightly (-2 points); 2 = Lids fused, loosely (-1 point); 3 = Lids open, pinna flat, stays folded (0 points); 4 = Slightly curved pinna, soft with slow recoil (1 point); 5 = Well-curved pinna, soft but ready recoil (2 points); 6 = Formed and firm, with instant recoil (3 points); 7 = Thick cartilage, ear stiff (4 points); NA=Not Available/Not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036417,Male genitals,ext_mgmt_bv_mib_st::gagenm,13,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,"13. Genitals, Male","1 = Scrotum flat, smooth (-1 point); 2 = Scrotum empty, faint rugae (0 points); 3 = Testes in upper cannal, rare rugae (1 point); 4 = Testes descending, few rugae (2 points); 5 = Testes down, good rugae (3 points); 6 = Testes pendulous, deep rugae (4 points); 7 = NA, the child is female (0 points), 99 = missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036411,Female genitals,ext_mgmt_bv_mib_st::gagenf,14,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,"Genitals, Female","1 = Clitoris prominent, labia flat (-1 point); 2 = Prominent clitoris, small labia minora (0 points); 3 = Prominent clitoris, enlarging minora (1 point); 4 = Majora and minora equally prominent (2 points); 5 = Majora large, minora small (3 points); 6 = Majora cover clitoris and minora (4 points); 7 = NA, the child is male (0 points); NA=Not Available/Not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036414,Gestational age score,ext_mgmt_bv_mib_st::gascor,15,ext_mgmt_bv_mib_st,Total score based on all gestational age categories.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,15. TOTAL SCORE,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036409,Estimated gestational age,ext_mgmt_bv_mib_st::gaega,16,ext_mgmt_bv_mib_st,Based on the calculated gestational age score.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,Estimated Gestational Age,,variable,,,,PROVIDE Randomized Controlled Trial,,weeks,http://purl.obolibrary.org/obo/UO_0000034,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036420,Posture,ext_mgmt_bv_mib_st::gapos,2,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,2. Posture,"1 = Arms and legs extended (0 points ); 2 = Slight or moderate flexion of hips and knees (1 point); 3 = Moderate to strong flexion of hips and knees (2 points); 4 = Legs flexed and abducted, arms slightly flexed (3 points); 5 = Full flexion of arms and legs (4 points);
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036425,Square window,ext_mgmt_bv_mib_st::gasqrw,3,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,Square window,1 = >90 degrees (-1 point); 2 = 90 degrees (0 points); 3 = 60 degrees (1 point); 4 = 45 degrees (2 points); 5 = 30 degrees (3 points); 6 = 0 degrees (4 points); NA=Not Available/Not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036405,Arm recoil,ext_mgmt_bv_mib_st::gaarm,4,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,4. Arm recoil,"1 = Remains extended 180 degrees, or random movements (0 points); 2 = Minimal flexion, 140-180 degrees (1 point); 3 = Small amount of flexion, 110-140 degrees (2 points); 4 = Moderate flexion, 90-100 degrees (3 points); 5 = Brisk return to full flexion, <90 degrees (4 points);
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036419,Popliteal angle,ext_mgmt_bv_mib_st::gapop,5,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,5. Popliteal angle,"1 = 180 degrees (-1 point); 2 = 160 degrees (0 points); 3 = 140 degrees (1 point); 4 = 120 degrees (2 points); 5 = 100 degrees (3 points); 6 = 90 degrees (4 points); 7 = <90 degrees (5 points);
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036423,Scarf sign,ext_mgmt_bv_mib_st::gascrf,6,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,6. Scarf sign,1 = Elbow reaches or nears level of opposite shoulder (-1 point); 2 = Elbow crosses opposite anterior axillary line (0 points); 3 = Elbow reaches opposite anterior axillary line (1 point); 4 = Elbow at midline (2 points); 5 = Elbow does not reach midline (3 points); 6 = Elbow does not cross proximate axillary line (4 points); NA=Not Available/Not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036415,Heel to ear,ext_mgmt_bv_mib_st::gaheel,7,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,7. Heel to ear,"1= (-1 Point); 2=(0 points); 3=(1 points); 4=(2 points); 5=(3 points);  6=(4 points);;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036424,Skin,ext_mgmt_bv_mib_st::gaskin,8,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,8. Skin,"1 = Sticky, friable, transparent (-1 point); 2 = Gelatinous red, translucent (0 points); 3 = Smooth pink, visible veins (1 point); 4 = Superficial peeling and/or rash, few veins (2 points); 5 = Cracking, pale areas, rare veins (3 points); 6 = Parchment, deep cracking, no vessels (4 points); 7 = Leathery, cracked, wrinkled (5 points);
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036416,Lanugo,ext_mgmt_bv_mib_st::galanu,9,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036006,Gestational age assessment,Lanugo,1 = None (-1 point); 2 = Sparse (0 points); 3 = Abundant (1 point); 4 = Thinning (2 points); 5 = Bald areas (3 points); 6 = Mostly bald (4 points); NA=Not Available/Not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036553,Clinic referred to,ext_bv_ref_st::refto,,ext_bv_ref_st,Which clinic or hospital the participant was referrred to that day.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000308,Hospitalization,3. Place child referred to,1= ICDDRB Mirpur Hospital;  2=ICDDRB (Mohakhali); 3 =Mirpur Shishu/Children Hospital (Private); 4=Dhaka Shishu Hospital (Government); 5 =Radda Clinic; 6= Other,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036552,Referral reason,ext_bv_ref_st::refreas,,ext_bv_ref_st,The reason the participant was referrred to a clinic or hospital that day.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000308,Hospitalization,2. Reason for referral,1= Dehydration or diarrhea; 2= Malnutrition; 3= Respiratory illness; 4= Other,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031247,Oral poliovirus vaccine (OPV),ext_bv_f14::f14opv | ext_bv_f06::f6opv | ext_bv_f10::f10opv | ext_bv_f52::f52opv | ext_bv_f39::f39opv,1,ext_bv_f14 | ext_bv_f52 | ext_bv_f06 | ext_bv_f39 | ext_bv_f10,"Participants were supposed to receive OPV at 6, 10, 14, and 52 weeks. Depending on randomization, they were set to receive OPV or IPV at 39 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,6b.  Oral Polio Vaccine (OPV) | 5b.  Oral Polio Vaccine (OPV) | 5a. Oral Polio Vaccine (OPV) Treatment group A and C only),1=Yes; 2=No; 9=Missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031230,Inactivated poliovirus vaccine (IPV),ext_bv_f39::f39ipv,2,ext_bv_f39,"Depending on randomization, participants were set to receive OPV or IPV at 39 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,5b. Inactivated Polio Vaccine (IPV) Treatment group B and D only),1=Yes; 2=No; 9=Missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036102,Rotarix vaccine,ext_bv_f10::f10rt | ext_bv_f17::f17rt,3,ext_bv_f17 | ext_bv_f10,"Participants were randomized as to whether they would receive Rotarix or not, which was given at 10 and 17 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,5c. Rotarix (Groups A and B only | 5a. Rotarix (Treatment group A and B only),1=Yes; 2=No; 9=Missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036100,Bacille Calmette-Guerin (BCG) vaccine,ext_bv_f06::f6bcg,4,ext_bv_f06,Participants were supposed to receive BCG at 6 weeks if they didn't receive it at birth.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,6c. BCG (only if not given at birth),1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036101,Pentavalent vaccine,ext_bv_f14::f14pv | ext_bv_f06::f6pv | ext_bv_f10::f10pv,5,ext_bv_f14 | ext_bv_f06 | ext_bv_f10,"Participants were supposed to receive the pentavalent vaccine (diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenza type b) at 6, 10, and 14 weeks.",Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,6a. Pentavalent Vaccine | 5a. Pentavalent Vaccine,1=Yes; 2=No; 9=Missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036117,Measles vaccine,ext_bv_fan::fanms | ext_bv_f40::f40ms,6,ext_bv_f40 | ext_bv_fan,Participants were supposed to receive the measles vaccine at 40 and 65 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,6b. Measles | 5a.Measles Vaccine,1=Yes; 2=No; 9=Missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036118,Rubella vaccine,ext_bv_f40::f40rub,7,ext_bv_f40,Participants were supposed to receive the rubella vaccine at 40 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,6c. Rubella,1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036119,Vitamin A supplementation,ext_bv_f40::f40va,8,ext_bv_f40,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,6a. Vitamin A,1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036224,Siblings <5 years count,ext_bv_ses::sb5y,1,ext_bv_ses,Number of siblings the participant has that are under 5 years old.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,2c. Number of siblings under 5 years,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0035109,Mother's age,ext_bv_enm::mage,2,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,3. Age of woman in years,,variable,,,,PROVIDE Randomized Controlled Trial,EUPATH_0036077,years,http://purl.obolibrary.org/obo/UO_0000036,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036078,Mother's age at first marriage,ext_bv_enm::mrag,3,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,Age at first marriage,,variable,,,,PROVIDE Randomized Controlled Trial,,years,http://purl.obolibrary.org/obo/UO_0000036,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036082,Mother's marriages count,ext_bv_enm::mrno,4,ext_bv_enm,Number of marriages,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,Number of marriages,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036220,Mother's education level,ext_bv_ses::medu,5,ext_bv_ses,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,8b. Mother education,Refer BV_SESCODES.xls for codes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036221,Mother's occupation,ext_bv_ses::mocc,6,ext_bv_ses,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,9b. Mother Occupation,"Refer BV_SESCODES.xls for codes, 99= missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036218,Mother's living children count,ext_bv_ses::clive,7,ext_bv_ses,Number of living children that the participant's mother has.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,2a. Number of living children,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036213,Father's education level,ext_bv_ses::fedu,8,ext_bv_ses,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,8a. Father education,Refer BV_SESCODES.xls for codes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036214,Father's occupation,ext_bv_ses::focc,9,ext_bv_ses,,Participant,http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,9a. Father Occupation,"Refer BV_SESCODES.xls for codes, 99= missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
,Maternal observation details,,,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036147,Maternal data collection date,ext_bv_mfu_st::mbldt,,ext_bv_mfu_st,Collected at 6 weeks.,Participant,,Maternal observation details,1. Date of visit,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036148,Mother's height,ext_bv_mfu_st::mhtcm,,ext_bv_mfu_st,Collected at 6 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036012,Maternal anthropometry,3. Height of mother at weeks 6 in Cm,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036149,Mother's weight,ext_bv_mfu_st::mwtkg,,ext_bv_mfu_st,Collected at 6 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036012,Maternal anthropometry,2. Weight of the Mother at week 6 in Kg,999.99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036023,Maternal supplementation during pregnancy,,1,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036085,Other pregnancy supplements,ext_bv_enm::sotsp,2,ext_bv_enm,Other supplements the mother received during pregnancy.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,"12f1. If 'other', please specify",,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036084,Maternal tetanus vaccination count during pregnancy,ext_bv_enm::mtt,3,ext_bv_enm,Number of tetanus toxoid vaccinations the mother received during this pregnancy.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,Number of tetanus toxoid (TT) received during THIS Pregnancy,1 = None; 2 = One dose; 3=Two Doses; 7=Don<U+2019>t Know,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036080,Maternal age at menarche,ext_bv_enm::mnag,4,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,6. Age at menarche in years,,variable,,,,PROVIDE Randomized Controlled Trial,,years,http://purl.obolibrary.org/obo/UO_0000036,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036079,Maternal age at first pregnancy,ext_bv_enm::prgag,5,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,7. Age at first pregnancy,,variable,,,,PROVIDE Randomized Controlled Trial,,years,http://purl.obolibrary.org/obo/UO_0000036,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036355,Maternal Lewis secretor,ext_lab_bv_sspabm::secretor,6,ext_lab_bv_sspabm,Whether the participant's mother has the secretor (Se) allele.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,"Lewis Secretor status,<U+00A0>","Positive=1, Negative=2 and inconclusive=3  / 1= result_a+ve, result_b+ve OR 1= result_a-ve, result_b+ve; 2= result_a+ve, result_b-ve; 3 (Inconclusive)= result_a-ve, result_b-ve",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036356,Maternal Lewis type a,ext_lab_bv_sspabm::result_a,7,ext_lab_bv_sspabm,Whether the participant's mother is Lewis type a positive.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,Lewis Type 'a',Positive=1 and<U+00A0> Negative=2,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036357,Maternal Lewis type b,ext_lab_bv_sspabm::result_b,8,ext_lab_bv_sspabm,Whether the participant's mother is Lewis type b positive.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,Lewis Type 'b',Positive=1 and<U+00A0> Negative=2,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036073,Calcium,ext_bv_enm::cal,1,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036023,Maternal supplementation during pregnancy,Calcium,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036075,Folic acid,ext_bv_enm::folic,2,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036023,Maternal supplementation during pregnancy,12c. Folic acid,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036076,Iron,ext_bv_enm::iron,3,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036023,Maternal supplementation during pregnancy,Iron,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036087,Vitamin A,ext_bv_enm::vita,4,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036023,Maternal supplementation during pregnancy,Vitamin A,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036571,Zinc,ext_bv_enm::zinc,5,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036023,Maternal supplementation during pregnancy,12a. Zinc,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036560,Other,ext_bv_enm::spotr,6,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0036023,Maternal supplementation during pregnancy,12f. Other,1=Yes; 2=No;,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00031892,Acyclovir syrup,ext_bv_ptreat_st::syp__acyclovir,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00020757,Ambrox drops,ext_bv_ptreat_st::ambrox_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026717,Amlexanox (Apsol gel),ext_bv_ptreat_st::amlexanox_.apsol_gel.,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00000904,Amoxicillin syrup,ext_bv_ptreat_st::syp__amoxycillin,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036561,Antacid tablet,ext_bv_ptreat_st::tab__antacid,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00031951,Aquaphen syrup,ext_bv_ptreat_st::aquaphen_syp,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00020873,Azithromycin syrup,ext_bv_ptreat_st::syp__azythromycin,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00051859,Baby zinc tablet,ext_bv_ptreat_st::tab__baby_zinc,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036565,Betapen tablet,ext_bv_ptreat_st::tab__butapen,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026161,Betson cream,ext_bv_ptreat_st::betson_cream,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026172,Calamine lotion,ext_bv_ptreat_st::calamine_lotion,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00020551,Ceevit,ext_bv_ptreat_st::ceevit,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00021182,Cefixime suspension,ext_bv_ptreat_st::cefixime_sup_.cef.3.,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_3504,Cefpodoxime,ext_bv_ptreat_st::cefodoxime,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001126,Ceftriaxone injection,ext_bv_ptreat_st::inj__ceftriaxone,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_3547,Cephradine,ext_bv_ptreat_st::cephradin,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00021212,Cetirizine alatrol,ext_bv_ptreat_st::cetrizine_.alatrol.,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001123,Chloramphenicol eye drops,ext_bv_ptreat_st::cloramphenical_eye_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00021279,Chlorpheniramine maleate syrup,ext_bv_ptreat_st::syp__chlorpheniramine_m,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00032549,Cipro ear drops,ext_bv_ptreat_st::cipro_ear_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00021346,Ciprofloxacin syrup,ext_bv_ptreat_st::syp__ciprofloxacin,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001106,Clotrimazole cream,ext_bv_ptreat_st::clotrimazole_cream,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00021406,Clotrimazole ear drops,ext_bv_ptreat_st::cotrimazole_ear_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_22723,Compound benzoic acid,ext_bv_ptreat_st::compound_benzoic_acid,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00032047,Cotrimoxazole syrup,ext_bv_ptreat_st::syp__cotrimoxasole,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00030841,Desloratadine syrup,ext_bv_ptreat_st::syp__desloratadine,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001117,Dexamethasone injection,ext_bv_ptreat_st::inj__dexamethasone,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00021569,Diazepam tablet,ext_bv_ptreat_st::tab_diazepam,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00021596,Dicycloverine hydrochloride,ext_bv_ptreat_st::dycyclovarine_hcl,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00030554,Erythromycin syrup,ext_bv_ptreat_st::syp__erythromycin,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00031432,Fexofenadine,ext_bv_ptreat_st::fexiphenadine,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00023392,Flacol drops,ext_bv_ptreat_st::flacol_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00031867,Flucloxacillin syrup,ext_bv_ptreat_st::syp__flucloxacillin,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00031946,Fluconazole syrup,ext_bv_ptreat_st::syp__fluconazole,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001104,Folic acid tablet,ext_bv_ptreat_st::tab__folic_acid,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036551,Fungidal ointment,ext_bv_ptreat_st::fungidal_ointment,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00775058,Gentamicin ear drops,ext_bv_ptreat_st::gentamycinr_ear_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001114,Gentamicin injection,ext_bv_ptreat_st::gentamycine_inj_,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00028948,Gentin ointment,ext_bv_ptreat_st::gentin_ointment,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00022040,Glycerine suppository,ext_bv_ptreat_st::glycerine_suppository,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00022124,Hydroxyzine hydrochloride syrup,ext_bv_ptreat_st::syp__hydroxyzine_hcl,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00020613,Ibruprofen syrup,ext_bv_ptreat_st::ibruprofen_syp,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036563,Iron supplement (Compiron),ext_bv_ptreat_st::iron_supplement_.comperon.,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026073,Ketoconazole shampoo,ext_bv_ptreat_st::ketakonazole_shampoo,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00017034,Ketotifen,ext_bv_ptreat_st::ketotifen,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00023027,Konakion injection (vitamin K),ext_bv_ptreat_st::inj__konakion_._vit.k.,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026595,Lactulose syrup,ext_bv_ptreat_st::lactulose_syp,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036548,Levosalbutamol syrup,ext_bv_ptreat_st::syp__levosulbutamol,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00022367,Mebendazole syrup,ext_bv_ptreat_st::syp._mebendazole,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00030925,Mefenamic acid,ext_bv_ptreat_st::mefenamic_acid,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001138,Metronidazole syrup,ext_bv_ptreat_st::syp__metronidzole,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00027639,Miconazole oral gel,ext_bv_ptreat_st::miconazole_oral_gel,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026889,Montelukast,ext_bv_ptreat_st::montelukast,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00030873,Moxclav syrup,ext_bv_ptreat_st::syp__moxaclave,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00027970,Moxifloxacin eye drops,ext_bv_ptreat_st::moxifloxacine_eye_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036550,Multi vitamin drops,ext_bv_ptreat_st::multi_vitamin_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00022621,Naproxen syrup,ext_bv_ptreat_st::syp_naproxen,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036562,Nebanol powder,ext_bv_ptreat_st::nebanol_powder,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036547,Nebulization,ext_bv_ptreat_st::nabulization,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026927,Nitazoxanide syrup,ext_bv_ptreat_st::syp__nitazoxanide,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00022711,Nitrazepam tablet,ext_bv_ptreat_st::tab_nitrazipum,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00020431,Norsol nasal drops,ext_bv_ptreat_st::norsal_nasal_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001109,Nystatin suspension,ext_bv_ptreat_st::nystatin_suspension,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00021709,Omidon syrup,ext_bv_ptreat_st::omidon_syp,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00022759,Ondansetron syrup,ext_bv_ptreat_st::ondensetron_syp,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036549,Oral rehydration salts ORS,ext_bv_ptreat_st::ors,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00022806,Oxicone,ext_bv_ptreat_st::oxicone,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00020467,Paracetamol syrup,ext_bv_ptreat_st::syp__paracetamol,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026326,Permethrin cream,ext_bv_ptreat_st::permethrin_cream,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00023088,Potassium syrup (Electro K),ext_bv_ptreat_st::syp__pottasium_.electrok.,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00024920,Povidone ointment,ext_bv_ptreat_st::povidon_ointment,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001509,Prednisolone tablet,ext_bv_ptreat_st::tab_prednisolone,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036564,Pushtikona,ext_bv_ptreat_st::pustikona,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00027488,Ranitidine syrup,ext_bv_ptreat_st::ranitidine_syp,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00023306,Riboflavin tablet,ext_bv_ptreat_st::tab__riboflavin,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00001511,Salbutamol syrup,ext_bv_ptreat_st::syp__sulbutamol,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00026348,Silver sulfadiazine (Burnsil),ext_bv_ptreat_st::silver_sulfazidine_._burmsil.,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00027939,Tetrasol,ext_bv_ptreat_st::tetrasol,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00023558,Theophylline,ext_bv_ptreat_st::theophyline,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00025989,Tobramycin eye drops,ext_bv_ptreat_st::tobramicine_eye_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00025987,Xylometazoline drop,ext_bv_ptreat_st::xylometazoline_drop,,ext_bv_ptreat_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,,value,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0004991,Observation date,ext_bv_flm::flmdt | ext_bv_ref_st::refdt | ext_mgmt_bv_danth::vstdate | ext_bv_f10::f10dt | ext_bv_neb_st::date | ext_bv_dir_st::dov | ext_bv_f17::f17dt | ext_bv_f53::f53dt | ext_bv_dep_st::deindt | ext_bv_f40::f40dt | ext_bv_f06::f6dt | ext_bv_f18::f18dt | ext_bv_f14::f14dt | ext_bv_ptreat_st::dov | ext_mgmt_bv_ddep_st::epidate | ext_bv_f39::f39dt | ext_bv_fan::fandt | ext_bv_sae_st::saerdt | ext_mgmt_bv_aed_st::aedt | ext_bv_f52::f52dt | ext_bv_pdv_st::pdvdt | ext_bv_f104::f104dt,1,ext_bv_ptreat_st | ext_mgmt_bv_aed_st | ext_bv_dir_st | ext_bv_flm | ext_bv_ref_st | ext_bv_f104 | ext_bv_f14 | ext_bv_pdv_st | ext_mgmt_bv_danth | ext_bv_f52 | ext_bv_f53 | ext_bv_neb_st | ext_bv_f18 | ext_bv_f06 | ext_bv_f40 | ext_mgmt_bv_ddep_st | ext_bv_dep_st | ext_bv_f39 | ext_bv_f17 | ext_bv_f10 | ext_bv_sae_st | ext_bv_fan,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000310,Observation details,Date of Specimen Collection dd/mm/yy | Date of visit (Drug received date) | 1. Date of Referral | 1. Date of assessment | Visit Date | Date of nebulization (derived by ST by restructing 8 variables into 1) | 3. Date of Protocol Deviation | 1. Date of Interview | 1. Date of visit,9/9/99 = missing | 09/09/1999=not done,variable,yes,yes,,PROVIDE Randomized Controlled Trial,,,,yes,,,,,
http://purl.obolibrary.org/obo/BFO_0000015,Observation type,ext_lab_bv_cmvrt::vstnum | ext_bv_sae_st::vstnum | ext_lab_bv_cytmp::vstnum | ext_bv_dir_st::vstnum | ext_lab_bv_cytcp::vstnum | ext_mgmt_bv_danth::vstnum | ext_bv_flm::flmvn | ext_lab_bv_rals::vstnum | ext_lab_bv_rpliga::vstnum | ext_mgmt_bv_ddep_st::vstnum | ext_bv_pdv_st::vstnum | ext_mgmt_pso_18_st::vstnum | ext_lab_bv_egf::vstnum | ext_bv_f39::f39vn | ext_lab_bv_polpcr::vstnum | ext_bv_fan::fanvn | ext_lab_bv_neop::vstnum | ext_lab_bv_rbmiga::vstnum | ext_lab_bv_bml_st::vstnum | ext_bv_f17::f17vn | ext_bv_f18::f18vn | ext_lab_bv_fer::vstnum | ext_lab_bv_cytbm::vstnum | ext_lab_bv_vac_st::vstnum | ext_lab_bv_speclog_is_st::vstnum | ext_lab_bv_qpcr::vstnum | ext_lab_bv_speclog_iu_st::vstnum | ext_bv_fci::vnum | ext_bv_mfu_st::vstnum | ext_mgmt_psi1_2_3_st::vstnum | ext_lab_bv_mpo::vstnum | ext_lab_bv_pcr::vstnum | ext_lab_bv_rpligg::vstnum | ext_lab_bv_crp::vstnum | ext_bv_neb_st::vstnum | ext_lab_bv_rbp::vstnum | ext_bv_f52::f52vn | ext_lab_bv_act::vstnum | ext_mgmt_bv_lmratio::lmwk | ext_bv_f06::f6vn | ext_lab_bv_speclog_vsp_st::vstnum | ext_lab_bv_mfge8::vstnum | ext_lab_bv_polsna_infant_st::vstnum | ext_bv_fcs_st::vstnum | ext_lab_bv_endotox::vstnum | ext_lab_bv_ctu::vstnum | ext_bv_rss_st::vstnum | ext_lab_bv_polsna_mother_st::vstnum | ext_bv_bsc::vnum | ext_lab_bv_speclog_cs_st::vstnum | ext_bv_dsmicr_st::vstnum | ext_bv_f104::f104vn | ext_lab_bv_dsgene::vstnum | ext_lab_bv_scd14::vstnum | ext_lab_bv_polcul::vstnum | ext_lab_bv_reg1b_upd1::vstnum | ext_lab_bv_speclog_fc_st::vstnum | ext_bv_f40::f40vn | ext_lab_bv_speclog_ib_st::vstnum | ext_lab_bv_tacd::vstnum | ext_bv_f10::f10vn | ext_lab_bv_pcrproto::vstnum | ext_lab_bv_pals::vstnum | ext_bv_ref_st::vstnum | ext_lab_bv_vitd::vstnum | ext_lab_bv_lps_upd1::vstnum | ext_lab_bv_speclog_ds_st::vstnum | ext_bv_f53::f53vn | ext_lab_bv_tac::vstnum | ext_lab_bv_speclog_vsr_st::vstnum | ext_lab_bv_ctt::vstnum | ext_lab_bv_calp::vstnum | ext_lab_bv_cmv::vstnum | ext_mgmt_bv_mib_st::vstnum | ext_mgmt_bv_aed_st::vstnum | ext_bv_ps1_2_st::vstnum | ext_lab_bv_rotavs::vstnum | ext_lab_bv_zn::vstnum | ext_lab_bv_speclog_bm_st::vstnum | ext_bv_dep_st::vstnum | ext_lab_bv_ala::vstnum | ext_bv_f14::f14vn | ext_bv_ptreat_st::vstnum | ext_bv_sbo::sbvn | ext_lab_bv_speclog_mb_st::vstnum,2,ext_lab_bv_vac_st | ext_lab_bv_act | ext_lab_bv_cmv | ext_lab_bv_ctt | ext_lab_bv_lps_upd1 | ext_lab_bv_rpligg | ext_lab_bv_vitd | ext_lab_bv_rbp | ext_lab_bv_crp | ext_lab_bv_scd14 | ext_lab_bv_rals | ext_lab_bv_speclog_ib_st | ext_lab_bv_cytcp | ext_lab_bv_pals | ext_lab_bv_ctu | ext_lab_bv_polsna_infant_st | ext_mgmt_pso_18_st | ext_lab_bv_fer | ext_lab_bv_rpliga | ext_lab_bv_endotox | ext_lab_bv_zn | ext_bv_ptreat_st | ext_mgmt_bv_aed_st | ext_bv_dir_st | ext_bv_flm | ext_bv_ref_st | ext_bv_f104 | ext_bv_f14 | ext_bv_pdv_st | ext_mgmt_bv_danth | ext_bv_f52 | ext_bv_f53 | ext_bv_neb_st | ext_bv_f18 | ext_bv_f06 | ext_bv_f40 | ext_mgmt_bv_ddep_st | ext_bv_dep_st | ext_bv_f39 | ext_bv_f17 | ext_bv_f10 | ext_bv_sae_st | ext_bv_fan | ext_lab_bv_pcr | ext_bv_sbo | ext_lab_bv_cytmp | ext_lab_bv_cytbm | ext_bv_bsc | ext_bv_dsmicr_st | ext_bv_fcs_st | ext_mgmt_bv_mib_st | ext_bv_ps1_2_st | ext_bv_rss_st | ext_bv_fci | ext_lab_bv_tacd | ext_lab_bv_tac | ext_lab_bv_polcul | ext_lab_bv_bml_st | ext_bv_mfu_st | ext_mgmt_psi1_2_3_st | ext_lab_bv_speclog_iu_st | ext_lab_bv_polsna_mother_st | ext_lab_bv_pcrproto | ext_mgmt_bv_lmratio | ext_lab_bv_neop | ext_lab_bv_qpcr | ext_lab_bv_dsgene | ext_lab_bv_speclog_vsp_st | ext_lab_bv_speclog_ds_st | ext_lab_bv_speclog_vsr_st | ext_lab_bv_speclog_cs_st | ext_lab_bv_speclog_fc_st | ext_lab_bv_polpcr | ext_lab_bv_mfge8 | ext_lab_bv_speclog_mb_st | ext_lab_bv_rbmiga | ext_lab_bv_mpo | ext_lab_bv_rotavs | ext_lab_bv_speclog_is_st | ext_lab_bv_cmvrt | ext_lab_bv_speclog_bm_st | ext_lab_bv_calp | ext_lab_bv_egf | ext_lab_bv_ala | ext_lab_bv_reg1b_upd1,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000310,Observation details,2. Visit Number | Visit number | 1. Visit number | Derived by ST for loading with daily surveillance data | Visit week,"#NAME? | 11 = Week 52, 99= missing | 12 = Week 53-56 | 01 = Week 17 | 05 = Week 14 | 09 = Week 39 | 2 = Week 6 | 06 = Week 17 | 07 = Week 18 | 3 = Week 10 | 14 = Week 65; 15-Week 78; 16=Week 91 | 04= Week 12 ; 08 = Week 24 | 10=Clinic stool; 11=Viral shedding stool; 12=diarrheal stool; 13=Fecal cytokine stool; 33=InfantBlood;44= Infatn Urine; 55=Breast Milk; 66=MotherBlood; 77=Infant saliva | 5 = Week 14, 11 = Week 52 | 13= Week 104 | 15 = Week 78; 13 = Week 104 | 10= Week 40",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,yes,,,,,
http://purl.obolibrary.org/obo/OBI_0001169,Age,ext_mgmt_bv_danth::ageday | ext_bv_bsc::age | ext_bv_neb_st::aged | ext_mgmt_bv_ddep_st::daysbirth,3,ext_mgmt_bv_danth | ext_bv_neb_st | ext_mgmt_bv_ddep_st | ext_bv_bsc,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000310,Observation details,Age in days since birth | Age in days at nebulization treatment (derived by ST by restructuring 8 variables into 1) | days since birth to the episode | 3. Age in days,,variable,yes,yes,,PROVIDE Randomized Controlled Trial,EUPATH_0000579,days,http://purl.obolibrary.org/obo/UO_0000033,yes,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000191,Time since enrollment,ext_mgmt_bv_ddep_st::daysenc | ext_mgmt_bv_danth::daysenc,4,ext_mgmt_bv_danth | ext_mgmt_bv_ddep_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000310,Observation details,Days since enrollment for each episode | Days since enrollment,,variable,yes,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036081,Maternal live birth count,ext_bv_enm::lvbrt,1,ext_bv_enm,"Total number of live births in lifetime, including the participant's birth.",Participant,http://purl.obolibrary.org/obo/ONTONEO_00000225,Obstetric history,Total live births in lifetime (Including the current one),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036083,Maternal non-live birth pregnancy count,ext_bv_enm::mtp,2,ext_bv_enm,"Number of still births, deaths, abortions, menstural regulations, or DE&C (dilation, evacuation and curettage).",Participant,http://purl.obolibrary.org/obo/ONTONEO_00000225,Obstetric history,"9. Number of still birth/death/ abortion/MR, DE&C",,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010035,Administrative information,,1,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010037,Individuals related to participant,,10,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0020004,Aggregated illness data,,12,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000310,Observation details,,13,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000649,Anthropometry,,14,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036012,Maternal anthropometry,,14,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010947,Immunization and prevention,,16,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000083,Physical examination,,17,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,,17,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,,18,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000073,Diagnosis,,19,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,,2,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010016,Diarrheal episodes,,20,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000308,Hospitalization,,22,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OAE_0000001,Adverse events,,23,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,,24,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011730,Breastfeeding,,,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000678,Feeding,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036002,Bayley scales of infant and toddler development,,26,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036005,Family care indicators,,27,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C131844,Edinburgh postnatal depression scale,,28,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,,29,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010981,Demographics,,3,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,,4,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000015,Clinical history,,5,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036493,Maternal clinical history,,6,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/ONTONEO_00000225,Obstetric history,,7,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000678,Feeding,,8,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0022068,Relocation,,9,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000096,Participant,,,category,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0012223,ABO blood group,ext_lab_bv_abo::abo,1,ext_lab_bv_abo,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,Blood group,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036296,HLA-B allele 1,ext_lab_bv_hla::b_1,10,ext_lab_bv_hla,Class I alpha-chain. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - B allele 1,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036297,HLA-B allele 2,ext_lab_bv_hla::b_2,11,ext_lab_bv_hla,Class I alpha-chain. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - B allele 2,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036298,HLA-DQA1 allele 1,ext_lab_bv_hla::dqa1_1,12,ext_lab_bv_hla,DQ alpha-chain as expressed. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - DQA1 allele 1,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036299,HLA-DQA1 allele 2,ext_lab_bv_hla::dqa1_2,13,ext_lab_bv_hla,DQ alpha-chain as expressed. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - DQA1 allele 2,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036300,HLA-DQB1 allele 1,ext_lab_bv_hla::dqb1_1,14,ext_lab_bv_hla,DQ beta-chain as expressed. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - DQB1 allele 1,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036301,HLA-DQB1 allele 2,ext_lab_bv_hla::dqb1_2,15,ext_lab_bv_hla,DQ beta-chain as expressed. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - DQB1 allele 2,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036302,HLA-DRB1 allele 1,ext_lab_bv_hla::drb1_1,16,ext_lab_bv_hla,"DR beta1-chain determining specificities DR1, DR2, DR3, DR4, DR5‚àö√§etc. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.",Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - DRB1 allele 1,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036303,HLA-DRB1 allele 2,ext_lab_bv_hla::drb1_2,17,ext_lab_bv_hla,"DR beta1-chain determining specificities DR1, DR2, DR3, DR4, DR5‚àö√§etc. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.",Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - DRB1 allele 2,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036304,"HLA-DRB3,4,5 allele 1",ext_lab_bv_hla::drb345_1,18,ext_lab_bv_hla,"DR _3-chain determining DR52 and Dw24, Dw25, Dw26 specificities, DR _4-chain determining DR53, or DR _5-chain determining DR51. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.",Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,"HLA - DRB3,4,5 allele 1",,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036305,"HLA-DRB3,4,5 allele 2",ext_lab_bv_hla::drb345_2,19,ext_lab_bv_hla,"DR _3-chain determining DR52 and Dw24, Dw25, Dw26 specificities, DR _4-chain determining DR53, or DR _5-chain determining DR51. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.",Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,"HLA - DRB3,4,5 allele 2",,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0012224,Rh blood group,ext_lab_bv_abo::rh,2,ext_lab_bv_abo,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,rhesus macques postive status,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036258,CREM genotype,ext_lab_bv_crem-prkca::crem,3,ext_lab_bv_crem-prkca,The genotype for the top Entamoeba histolytica-associated SNP in CREM (rs2148483_A). This is in an additive format for the minor (risk) allele.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,rs2148483_A.  The genotype for the top Entamoeba histolytica -associated SNP in CREM. This is in an additive format for the minor (risk) allele.,"0=GG, 1=AG, 2=AA, NA=missing.",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036259,PRKCA genotype,ext_lab_bv_crem-prkca::prkca,4,ext_lab_bv_crem-prkca,The genotype for the top cryptosporidium-associated SNP in PRKCA (rs58296998_T). This is in an additive format for the minor (risk) allele.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,rs58296998_T. The genotype for the top cryptosporidium-associated SNP in PRKCA. This is in an additive format for the minor (risk) allele.,"0=CC, 1=CT, 2=TT, NA=missing.",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036306,Leptin receptor genotype,ext_lab_bv_lep::genotype,5,ext_lab_bv_lep,"Uses the marker C___8722581_10 which tests for Q223R in the leptin receptor. A codes to glutamine (Q), while G codes to arginine (R)",Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,Call,NN=Ambiguous/Undetermined,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036343,Lewis type,ext_lab_bv_rptype::letype,6,ext_lab_bv_rptype,The Lewis type category of the participant. a+ b- implies the participant has the Le allele but not the Se allele. a- b+ implies the participant has the Le allele and the Se allele. a- b- implies the participant has the Le recessive allele and may or may not have the Se allele. a+ b+ can be seen transiently in infants since secretor function increase with age or can suggest the participant has a weak Se allele.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,Lewis type category,1=a+ b-; 2=a- b+; 3=a- b-; 4=a+ b+; 99= not done,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036342,Lewis secretor,ext_lab_bv_rptype::secretor,7,ext_lab_bv_rptype,Whether the participant has the secretor (Se) allele.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,"Lewis Secretor status,<U+00A0>","Positive=1, Negative=2 and inconclusive=3  / 1= result_a+ve, result_b+ve OR 1= result_a-ve, result_b+ve; 2= result_a+ve, result_b-ve; 3 (Inconclusive)= result_a-ve, result_b-ve",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036294,HLA-A allele 1,ext_lab_bv_hla::a_1,8,ext_lab_bv_hla,Class I alpha-chain. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - A allele 1,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036295,HLA-A allele 2,ext_lab_bv_hla::a_2,9,ext_lab_bv_hla,Class I alpha-chain. The values are formatted so the digits before the colon represent the allele group and the digits after the colon represent the specific HLA protein.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000306,Participant genotype,HLA - A allele2,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000120,Age at enrollment,ext_mgmt_bv_mib_st::cage,1,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,Child Age,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011147,Age at last contact,ext_mgmt_bv_mib_st::dropage,2,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,Termination age,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000151,Enrollment date,ext_mgmt_bv_mib_st::endt | ext_bv_enm::mendt,3,ext_bv_enm | ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,1. Date of Enrollment | 2. Date of enrollment,9/9/99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036074,Enrollment location,ext_bv_enm::menpl,4,ext_bv_enm,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,Place of Enrollment,1 = Home; 2 = Health facility,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010502,Total illness surveillance time,ext_mgmt_bv_ddep_st::srvydays,5,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,Days of observation,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036113,Study completion date,ext_bv_f104::f104cdt,6,ext_bv_f104,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,9a. Date of subject study completion (mother and infant),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036479,Withdrawal before 731 days old,ext_mgmt_rto2::drop730,7,ext_mgmt_rto2,Participant was dropped/terminated at age < 731.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,Was the infant dropped/terminated at age < 731,0=No; 1=Yes,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000208,Reason for withdrawal,ext_mgmt_bv_mib_st::tereas,8,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,4. Reason for discontinuation,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0020259,Withdrawal date,ext_mgmt_bv_mib_st::terdis,9,ext_mgmt_bv_mib_st,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000307,Participant study details,3. Date of study discontinuation,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000110,Temperature,ext_mgmt_bv_ddep_st::temp | ext_bv_dep_st::deptemp | ext_bv_dir_st::temp,,ext_bv_dir_st | ext_mgmt_bv_ddep_st | ext_bv_dep_st,Assessed at home visits twice weekly and during diarrheal episodes.,Participant,http://purl.obolibrary.org/obo/OGMS_0000083,Physical examination,Auxillary Temperature measured today <U+00A9> | Temperature recorded during that episode,99.9 = missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,C,http://purl.obolibrary.org/obo/UO_0000027,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031079,Vesikari axillary temperature,ext_mgmt_bv_ddep_st::feversc,,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/OGMS_0000083,Physical examination,Score assigned to variable Temp to derive RUUSKA: E . *If more than one clinical form is completed- used the maximum fever code for that episode,0 = <=37 C; 1 = 37.1-38.4 C; 2 = 38.5-38.9 C; 3 = >= 39 C,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036570,Individual with protocol deviation,ext_bv_pdv_st::pdvwho,1,ext_bv_pdv_st,Who experienced the protocol deviation.,Participant,http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,2. Form completed for,1=Mother; 2=Infant,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036539,Protocol deviation type,ext_bv_pdv_st::pdvtype,2,ext_bv_pdv_st,Type of protocol deviation that occurred that day.,Participant,http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,5. Type of devaiton?,"01=Missed visit, 02=Missed specimen, 03=Missed shedding specimen, 04=Missed procedure, 05=Missed specimen + procedure, 06=Blood specimen collected outside visit window, 07=Urine specimen collected outside visit window, 08=Stool specimen collected outside visit window, 09=Breast milk specimen collected outside visit window, 10=Visit occurred outside of window, 11=Vaccination outside clinic, 12=Incorrectly vaccinated, 13=Child received additional dose of OPV, 14=Other",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036541,Other protocol deviation type,ext_bv_pdv_st::pdtyspec,3,ext_bv_pdv_st,Other type of protocol deviation that occurred that day specified.,Participant,http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,"5a. If deviation type other, please specify",,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036543,Protocol deviation reason,ext_bv_pdv_st::pdvres,4,ext_bv_pdv_st,,Participant,http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,6. Reason for deviation?,1= Subject Illness; 2 = Suject unable; 3= Subject refusal; 4 = Clerical error; 5 = Investigator decision; 6 = Other,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036545,Other protocol deviation reason,ext_bv_pdv_st::pdrespec,5,ext_bv_pdv_st,Other reason for deviation specified.,Participant,http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,"6a. If reason other, please specify",,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036534,Adverse event due to protocol deviation,ext_bv_pdv_st::pdvae,6,ext_bv_pdv_st,Did the participant experience an adverse event due to this protocol deviation.,Participant,http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,7.  Is the deviation restult in Adverse event?,1=Yes; 2=No,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036535,Protocol deviation observation week,ext_bv_pdv_st::pdvstwk,7,ext_bv_pdv_st,The observation week associated with the protocol deviation.,Participant,http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,4. Visit week associated with protocol deviation,"01=Enrollment , 02=Week 06 , 03=Week 10, 04=Week 12, 05=Week 14,  06=Week 17, 07=Week 18 , 08=Week 24, 09=Week 39, 10=Week 40, 11=Week 52, 12=Week 53, 13=Week 104, 14=Week 65, 15=Week 78, 16= Week 91, 99=Not applicable",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036537,Protocol deviation report date,ext_bv_pdv_st::pdvrdt,8,ext_bv_pdv_st,The date the participant's deviation was reported.,Participant,http://purl.obolibrary.org/obo/NCIT_C50996,Protocol deviations,1. Date of Report,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036110,Raven's Progressive Matrices assessment date,ext_bv_f104::f104rvdt,1,ext_bv_f104,Completed at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,8d1. Date of assessment of Raven,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036155,RPM set B score,ext_bv_rvn::rvbscor,10,ext_bv_rvn,Raven's Progressive Matrices (RPM) set B score. Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,9. Total Set B score,99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036156,RPM set C score,ext_bv_rvn::rvcscor,11,ext_bv_rvn,Raven's Progressive Matrices (RPM) set C score. Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,10. Total Set C score,99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036157,RPM set D score,ext_bv_rvn::rvdscor,12,ext_bv_rvn,Raven's Progressive Matrices (RPM) set D score. Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,11. Total Set D score,99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036158,RPM set E score,ext_bv_rvn::rvescor,13,ext_bv_rvn,Raven's Progressive Matrices (RPM) set E score. Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,12. Total Set E score,99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036151,RPM score,ext_bv_rvn::rvtotal,14,ext_bv_rvn,Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,13. TOTAL RAVEN<U+2019>S SCORE,99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036111,Raven's Progressive Matrices completed,ext_bv_f104::f104rvn,2,ext_bv_f104,Completed at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,8d. Mother Raven<U+2019>s Progressive Matrices,"1=Yes; 2=No; 8 = Refused V7 consent;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036160,RPM test start time,ext_bv_rvn::strttime,3,ext_bv_rvn,Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,3. Test start time (24 hour scale),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036152,RPM section at 20 minutes,ext_bv_rvn::rvnsec,4,ext_bv_rvn,Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,4a. Section  number of the problem in progress at 20 minutes,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036150,RPM question at 20 minutes,ext_bv_rvn::rvnquest,5,ext_bv_rvn,Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,4a. Question number of the problem in progress at 20 minutes,99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036159,RPM test end time,ext_bv_rvn::endtime,6,ext_bv_rvn,Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,5. Test end time (24 hour scale),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036161,RPM total test time,ext_bv_rvn::totltime,7,ext_bv_rvn,Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,6. Total test time (in minutes),99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,min,http://purl.obolibrary.org/obo/UO_0000031,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036153,RPM set A score,ext_bv_rvn::rvascor,8,ext_bv_rvn,Raven's Progressive Matrices (RPM) set A score. Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,7. Total Set A score,99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036154,RPM set Ab score,ext_bv_rvn::rvabscor,9,ext_bv_rvn,Raven's Progressive Matrices (RPM) set Ab score. Assessed in mothers of participants  at 104 weeks.,Participant,http://purl.obolibrary.org/obo/EUPATH_0036024,Raven's progressive matrices,8. Total Set AB score,99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031101,IV or oral rehydration,ext_mgmt_bv_ddep_st::rehyd,,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0010024,Rehydration therapy,Rehydration treatment prescribed during that episode,"1 = None (0 points); 2 = ORS (1 point); 3 =  I.V. fluid (2 points), NA=Not available",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000377,Time living in dwelling,ext_bv_ses::lvhh,,ext_bv_ses,0 indicates they have lived there less than 1 year.,Participant,http://purl.obolibrary.org/obo/EUPATH_0022068,Relocation,3. How long have you lived in current household in years?,,variable,,,,PROVIDE Randomized Controlled Trial,,years,http://purl.obolibrary.org/obo/UO_0000036,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0021002,Symptoms,,1,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031285,Vesikari dehydration severity,ext_mgmt_bv_ddep_st::dehydsc,10,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Score assigned to variable dehydration to derive RUUSKA : F,"1 = 0 points; 2 = (2 points);       
3 = 3 points; NA=Not available",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031115,Vesikari maximum vomiting,ext_mgmt_bv_ddep_st::mxvomtsc,11,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode. Vesikari score assigned to maximum number of times vomited/day per diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Score assigned to variable Severity of vomiting  to derive RUUSKA : D,1 = 1; 2 = 2-4; 3 = >= 5,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031113,Vesikari vomiting duration,ext_mgmt_bv_ddep_st::vomdursc,12,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Score assigned to variable Duration of vomiting to derive RUUSKA : C,1 = 1 day; 2 = 2 days; 3 = >= 3 days,variable,yes,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011878,Symptoms by caregiver report,,2,,,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0024212,Blood in stool,ext_bv_dir_st::stbld,3,ext_bv_dir_st,"If diarrhea reported, assessed for each day of diarrheal episode.",Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Blood in stool,1=Yes; 2=No; 99=not available/done,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036492,Mucus in stool,ext_bv_dir_st::mucs,4,ext_bv_dir_st,"If diarrhea reported, assessed for each day of diarrheal episode.",Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Mucus in stool,1=Yes; 2=No; 99=not available/done,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031110,Dehydration severity,ext_mgmt_bv_ddep_st::dehyd,5,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,5.  Dehydration assessment (points for Ruuska score),"1 = None (0 points); 2 = Any one of the following symptoms (2 points): Skin tenting,Sunken eyes, Dry mucus membranes; 3 = More than one of the above symptoms (3 points), 9 = Missing",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036055,Vomiting frequency,ext_bv_dir_st::vomt,6,ext_bv_dir_st,Assessed for each day. Number of times vomited/day.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Vomiting (times/day),99 = missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036395,Max vomiting frequency,ext_mgmt_bv_ddep_st::vomsevrt,7,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode. Maximum number of times vomited/day.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Severity of vomiting (# of vomting/24 hours),,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000165,Vomiting duration,ext_mgmt_bv_ddep_st::vomtdays,8,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode. The number of days the participant experienced vomiting.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Duration of vomiting during the Diarrheal episode,,variable,yes,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031114,Vesikari diarrhea duration,ext_mgmt_bv_ddep_st::diadursc,9,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/EUPATH_0000309,Signs and symptoms,Score assigned to variable duration of diarrheal episode to derive RUUSKA: A,1 = 1 -  4 days; 2 = 5 days ; 3 = >= 6 days,variable,yes,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/HP_0002014,Diarrhea,ext_bv_dir_st::diar,,ext_bv_dir_st,Assessed for each day.,Participant,http://purl.obolibrary.org/obo/EUPATH_0021002,Symptoms,Diarrhea today?,99 = missing,variable,yes,,,PROVIDE Randomized Controlled Trial,DOID_13250,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036053,"Stool consistency, caregiver report",ext_bv_dep_st::decons,1,ext_bv_dep_st,Assessed once per diarrheal episode on the interview day.,Participant,http://purl.obolibrary.org/obo/EUPATH_0011878,Symptoms by caregiver report,4. Consistency of current stool,"1 = Normal, 2 = Loose, 3 = Liquid/Watery, 9 = missing",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010533,"Loose stools in day, caregiver report",ext_bv_dir_st::drno,2,ext_bv_dir_st,"If diarrhea reported, assessed for each day of diarrheal episode.",Participant,http://purl.obolibrary.org/obo/EUPATH_0011878,Symptoms by caregiver report,No. of diarrheal stool in last 24 hrs,99 = missing,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0015669,Diarrhea treatment,ext_bv_dep_st::antb,1,ext_bv_dep_st,Assessed once per diarrheal episode on the interview day.,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,7. Antibiotic treatment history for this episode,"1 = None; 
2 = Antibiotics taken pre-visit; 
3 = Antibiotics prescribed at visit, 9 = missing",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036566,Nebulizer treatment,ext_bv_neb_st::nebulizer,10,ext_bv_neb_st,Whether the participant received treatment with a nebulizer that day.,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,Derived by ST to indicate nebulizer treatment was provided,,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036050,Antibiotic prescribed,ext_bv_dep_st::antb1,2,ext_bv_dep_st,Assessed once per diarrheal episode on the interview day.,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,7a.1 Antibiotics 1,"01=Azithromycin; 02=Erythromycin; 03=Metronidazole; 04=Ciprofloxacin; 05=Nalidixic acid; 06=Pivmecillinam; 07=Cephradine; 08=Co-trimoxazole; 09=Amoxycillin; 10=Cefixime; 11=Ceftazidime; 12=Cefuroxime; 13=Ceftriaxone; 14=Flucloxacillin; 15=Other, 99 = Missing",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036051,Antibiotic prescribed 2,ext_bv_dep_st::antb2,3,ext_bv_dep_st,Assessed once per diarrheal episode on the interview day.,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,7a.2 Antibiotics 2,"01=Azithromycin; 02=Erythromycin; 03=Metronidazole; 04=Ciprofloxacin; 05=Nalidixic acid; 06=Pivmecillinam; 07=Cephradine; 08=Co-trimoxazole; 09=Amoxycillin; 10=Cefixime; 11=Ceftazidime; 12=Cefuroxime; 13=Ceftriaxone; 14=Flucloxacillin; 15=Other, 99 = Missing",variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0025092,Medication,,4,,Whether the participant received treatment with the indicated drugs that day. Extracted from participants medical records.,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010024,Rehydration therapy,,5,,,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0031145,Vesikari rehydration treatment,ext_mgmt_bv_ddep_st::rehydsc,6,ext_mgmt_bv_ddep_st,Assessed for each diarrheal episode.,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,Score assigned to variable rehydration prescribed during that episode to derive RUUSKA : G,1 = 0 points; 2 = 1 point; 3 =  2 points; NA=Not available,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011880,Antibiotic administration,,7,,,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010536,"ORT administered, caregiver report",ext_bv_dir_st::ors,8,ext_bv_dir_st,"If diarrhea reported, assessed for each day of diarrheal episode.",Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,Home use of ORS,1=Yes; 2=No; 99=not available/done,variable,yes,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036197,Small intestine bacterial overgrowth treatment,ext_bv_sbo::sbotreat,9,ext_bv_sbo,A 14 day course of trimethoprim-sulfamethoxazole and metronidazole was provided for SIBO. Assessed at 104 weeks.,Participant,http://purl.obolibrary.org/obo/OGMS_0000090,Treatment,6b. Treatment provided,1= Yes; 2= No;9=Not applicable,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,,,Sample,http://www.w3.org/2002/07/owl#Thing,,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,yes,,,,
http://purl.obolibrary.org/obo/EUPATH_0036028,Virus in stool detection aggregate data,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030114,Aggregate organism in stool detection data,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010734,"Hookworm, by microscopy",ext_bv_dsmicr_st::hkwrm,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0030118,Ancylostomatoidea in stool,11c. Hook worm,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011478,"Polio serotype 1 antibodies, by microneutralization",ext_mgmt_pso_st::sneg40s1,,ext_mgmt_pso_st,Assessed for sample from 40 weeks. A log2 <3 is considered negative.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011480,Antibodies,Sabin 1 Sero negative at week 40 (logs40s1 <=2.833),0=No; 1=yes; NA,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011398,"Polio serotype 2 antibodies, by microneutralization",ext_mgmt_pso_st::sneg40s2,,ext_mgmt_pso_st,Assessed for sample from 40 weeks. A log2 <3 is considered negative.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011480,Antibodies,Sabin 2 Sero negative at week 40 (logs40s2 <=2.833),0=No; 1=yes; NA,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011479,"Polio serotype 3 antibodies, by microneutralization",ext_mgmt_pso_st::sneg40s3,,ext_mgmt_pso_st,Assessed for sample from 40 weeks. A log2 <3 is considered negative.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011480,Antibodies,Sabin 3 Sero negative at week 40 (logs40s3 <=2.833),0=No; 1=yes; NA,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036059,"Ascaris, by microscopy",ext_bv_dsmicr_st::al,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0030119,Ascaris in stool,Ascaris,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036312,"Astrovirus, by qPCR",ext_lab_bv_pcr::astro,,ext_lab_bv_pcr,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011985,Astrovirus in stool,Astrovirus,"Positive = 1, Negative = 2, Inconclusive =3, -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011976,Escherichia in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011967,Bacteria in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036060,"Blastocystis hominis, by microscopy",ext_bv_dsmicr_st::bhomi,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036001,Blastocystis in stool,10e. Blastocystis hominis,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011480,Antibodies,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036031,Virus in blood,,,,,Sample,http://purl.obolibrary.org/obo/OBI_0002649,Blood microbiology test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036348,Blood quantity sufficient,ext_lab_bv_speclog_ib_st::qtty,,ext_lab_bv_speclog_ib_st,,Sample,http://purl.obolibrary.org/obo/OBI_0000655,Blood sample,Sample sufficient or not?,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0033146,Blood sample collected,ext_bv_f18::f18bld | ext_bv_f53::f53bld | ext_bv_f104::f104bld | ext_bv_f06::f6bld | ext_bv_f40::f40bld,1,ext_bv_f104 | ext_bv_f53 | ext_bv_f18 | ext_bv_f06 | ext_bv_f40,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011482,Blood sample collection process,6a. Blood (BVC-SID-33-04) | 7c. Blood (BVC-SID-33-03) | 6a. Blood (BVC-SID-33-02) | 7c. Blood (BVC-SID-33-05) | 7a. Blood (BVC-SID-33-01),1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0033147,Blood sample collection date,ext_lab_bv_endotox::specdt | ext_lab_bv_cmv::specdt | ext_lab_bv_lps_upd1::specdt | ext_lab_bv_ctu::specdt | ext_lab_bv_polsna_infant_st::specdt | ext_lab_bv_rpliga::specdt | ext_lab_bv_crp::specdt | ext_lab_bv_rals::specdt | ext_lab_bv_vitd::specdt | ext_mgmt_pso_st::specdt | ext_lab_bv_cytcp::specdt | ext_lab_bv_ctt::specdt | ext_lab_bv_speclog_ib_st::specdt | ext_lab_bv_rpligg::specdt | ext_lab_bv_scd14::specdt | ext_lab_bv_act::specdt | ext_lab_bv_zn::specdt | ext_lab_bv_rbp::specdt | ext_lab_bv_vac_st::specdt | ext_mgmt_pso_18_st::snadt18 | ext_lab_bv_pals::specdt | ext_lab_bv_fer::specdt,2,ext_lab_bv_vac_st | ext_lab_bv_act | ext_lab_bv_cmv | ext_mgmt_pso_st | ext_lab_bv_ctt | ext_lab_bv_lps_upd1 | ext_lab_bv_rpligg | ext_lab_bv_vitd | ext_lab_bv_rbp | ext_lab_bv_crp | ext_lab_bv_scd14 | ext_lab_bv_rals | ext_lab_bv_speclog_ib_st | ext_lab_bv_cytcp | ext_lab_bv_pals | ext_lab_bv_ctu | ext_lab_bv_polsna_infant_st | ext_mgmt_pso_18_st | ext_lab_bv_fer | ext_lab_bv_rpliga | ext_lab_bv_endotox | ext_lab_bv_zn,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011482,Blood sample collection process,Date of Specimen Collection dd/mm/yy,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036347,Blood collection comment,ext_lab_bv_speclog_ib_st::comment,3,ext_lab_bv_speclog_ib_st,Comment,Sample,http://purl.obolibrary.org/obo/EUPATH_0011482,Blood sample collection process,,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036144,Serum collected,ext_bv_flm::flmriga,4,ext_bv_flm,Done at 24 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011482,Blood sample collection process,7c. Serum for Rotavirus IgA  (Week 24 specimen BVC-SID-33-06),1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://www.ebi.ac.uk/efo/EFO_0004348,Hematocrit (%),ext_bv_flm::flmhct,1,ext_bv_flm,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,8.Hematocrit (%),999 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036496,Granulocyte-macrophage colony stimulating factor,ext_lab_bv_cytcp::gmcsf,10,ext_lab_bv_cytcp,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,GM-CSF Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036262,Interferon gamma,ext_lab_bv_cytcp::ifng | ext_lab_bv_ctu::ifng,11,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IFNG Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036264,Interleukin 1 beta,ext_lab_bv_cytcp::il1b | ext_lab_bv_ctu::il1b,12,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-1b Conc (pg/ml),0.00= below detectable limit; -9=missing or not done | -9.999 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036532,Interleukin 2,ext_lab_bv_cytcp::il2,13,ext_lab_bv_cytcp,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-2 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036265,Interleukin 4,ext_lab_bv_ctu::il4 | ext_lab_bv_cytcp::il4,14,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-4 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036266,Interleukin 5,ext_lab_bv_ctu::il5 | ext_lab_bv_cytcp::il5,15,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-5 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done | -9.999 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036267,Interleukin 6,ext_lab_bv_ctu::il6 | ext_lab_bv_cytcp::il6,16,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-6 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036268,Interleukin 7,ext_lab_bv_cytcp::il7 | ext_lab_bv_ctu::il7,17,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-7 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036269,Interleukin 8,ext_lab_bv_cytcp::il8 | ext_lab_bv_ctu::il8,18,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-8 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036263,Interleukin 10,ext_lab_bv_cytcp::il10 | ext_lab_bv_ctu::il10,19,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-10 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011849,Ferritin,ext_lab_bv_fer::fer,2,ext_lab_bv_fer,Assessed at 6 and 18 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,Ferritin ng/ml,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,ng/mL,http://purl.obolibrary.org/obo/UO_0000275,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036502,"Interleukin 12, p70",ext_lab_bv_cytcp::il12p70,20,ext_lab_bv_cytcp,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-12p70 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036504,Interleukin 13,ext_lab_bv_cytcp::il13,21,ext_lab_bv_cytcp,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-13 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036506,Interleukin 17A,ext_lab_bv_cytcp::il17a,22,ext_lab_bv_cytcp,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,IL-17A Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036270,Macrophage inflammatory protein 1 beta,ext_lab_bv_ctu::mip1b | ext_lab_bv_cytcp::mip1b,23,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,MIP1b Conc (pg/ml),0.00= below detectable limit; -9=missing or not done | -9.999 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036521,Monocyte chemoattractant protein 1,ext_lab_bv_cytcp::mcp1,24,ext_lab_bv_cytcp,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,MCP-1(MCAF) Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036336,Retinol Binding Protein,ext_lab_bv_rbp::rbp,25,ext_lab_bv_rbp,RBP concentration in blood was assessed at 6 and 18 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,Retinol Binding Protein (RBP) ng/ml,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,ng/mL,http://purl.obolibrary.org/obo/UO_0000275,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036344,Soluble CD14,ext_lab_bv_scd14::scd14,26,ext_lab_bv_scd14,"Assessed at 6, 18, and 40 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,Soluble CD14 measure in ng/ml,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,ng/mL,http://purl.obolibrary.org/obo/UO_0000275,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036271,Tumor necrosis factor alpha,ext_lab_bv_cytcp::tnfa | ext_lab_bv_ctu::tnfa,27,ext_lab_bv_cytcp | ext_lab_bv_ctu,"Assessed at 18, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,TNFAConc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011166,Zinc,ext_lab_bv_zn::zn,3,ext_lab_bv_zn,Assessed at 6 and 18 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,Zinc <U+00B5>g/L,'-9= Missing,variable,,,,PROVIDE Randomized Controlled Trial,EUPATH_0036394,ug/L,http://purl.obolibrary.org/obo/UO_0000301,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036393,Vitamin D,ext_lab_bv_vitd::vitd,4,ext_lab_bv_vitd,Assessed at 6 and 18 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,Vitamin D nmol/L,'-9= Missing,variable,,,,PROVIDE Randomized Controlled Trial,,nmol/L,http://purl.obolibrary.org/obo/EUPATH_0036573,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036293,Endotoxin,ext_lab_bv_endotox::endotox,5,ext_lab_bv_endotox,"Assessed by Limulus amebocyte lysate (LAL) assay at 6, 18, and 40 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,Endotoxin (Limulus Amebocytete Lysate) result EU/ml,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,EU/mL,http://purl.obolibrary.org/obo/EUPATH_0036576,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036307,Endotoxin core antibodies,ext_lab_bv_lps_upd1::lps,6,ext_lab_bv_lps_upd1,"Assessed antibody levels against alpha lippolysaccharide (LPS) at 6, 18, 40, 53, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,Alpha Lipopolysaccharide GMU/ml (Endocab),'-9= Missing,variable,,,,PROVIDE Randomized Controlled Trial,,GMU/mL,http://purl.obolibrary.org/obo/EUPATH_0036577,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036228,Activin A,ext_lab_bv_act::actvina,7,ext_lab_bv_act,"Assessed at 6, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,Activin A result pg/mL,0 ( <125 pg/ml) =below detectable limit; -9 = Missing,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0033154,C-reactive protein,ext_lab_bv_crp::crp,8,ext_lab_bv_crp,"Assessed at 6, 18, 40, 53, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,CRP mg/L,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,mg/L,http://purl.obolibrary.org/obo/UO_0000273,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036494,Granulocyte-colony stimulating factor,ext_lab_bv_cytcp::gcsf,9,ext_lab_bv_cytcp,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,G-CSF Conc  (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036172,Hydrogen at baseline,ext_bv_sbo::sbhbs,1,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4b1. Hydrogen (H2) ppm,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036177,Hydrogen at 180 min,ext_bv_sbo::sbh180,10,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4m1. Hydrogen (H2) ppm at 180 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036182,Methane at baseline,ext_bv_sbo::sbchbs,11,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4b2. Methane(CH4) ppm,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036187,Methane at 20 min,ext_bv_sbo::sbch20,12,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4e2. Methane(CH4) ppm at 20 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036188,Methane at 40 min,ext_bv_sbo::sbch40,13,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4f2. Methane (CH4) ppm at 40 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036189,Methane at 60 min,ext_bv_sbo::sbch60,14,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4g2. Methane (CH4) ppm at 60 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036190,Methane at 80 min,ext_bv_sbo::sbch80,15,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4h2. Methane (CH4) ppm at 80 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036191,Methane at 100 min,ext_bv_sbo::sbch100,16,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4i2. Methanee (CH4) ppm at 100 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036183,Methane at 120 min,ext_bv_sbo::sbch120,17,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4j2. Methane (CH4) ppm at 120 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036184,Methane at 140 min,ext_bv_sbo::sbch140,18,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4k2. Methane (CH4) ppm at 140 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036185,Methane at 160 min,ext_bv_sbo::sbch160,19,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4l2. Methane (CH4) ppm at 160 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036178,Hydrogen at 20 min,ext_bv_sbo::sbh20,2,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4e1. Hydrogen (H2) ppm at 20 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036186,Methane at 180 min,ext_bv_sbo::sbch180,20,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4m2. Methane (CH4) ppm at 180 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,52,2
http://purl.obolibrary.org/obo/EUPATH_0036162,Carbon dioxide at baseline,ext_bv_sbo::sbcobs,21,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4b3. Carbon Dioxide (CO2) ppm,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036168,Carbon dioxide at 20 min,ext_bv_sbo::sbco20,22,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4e3. Carbon Dioxide (CO2) ppm at 20 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036169,Carbon dioxide at 40 min,ext_bv_sbo::sbco40,23,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4f3. Carbon Dioxide (CO2) ppm at 40 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036170,Carbon dioxide at 60 min,ext_bv_sbo::sbco60,24,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4g3. Carbon Dioxide (CO2) ppm at 60 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036171,Carbon dioxide at 80 min,ext_bv_sbo::sbco80,25,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4h3. Carbon Dioxide (CO2) ppm at 80 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036163,Carbon dioxide at 100 min,ext_bv_sbo::sbco100,26,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4i3. Carbon Dioxide (CO2) ppm at 100 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036164,Carbon dioxide at 120 min,ext_bv_sbo::sbco120,27,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4j3. Carbon Dioxide (CO2) ppm at 120 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036165,Carbon dioxide at 140 min,ext_bv_sbo::sbco140,28,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4k3. Carbon Dioxide (CO2) ppm at 140 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036166,Carbon dioxide at 160 min,ext_bv_sbo::sbco160,29,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4l3. Carbon Dioxide (CO2) ppm at 160 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036179,Hydrogen at 40 min,ext_bv_sbo::sbh40,3,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4f1. Hydrogen (H2) ppm at 40 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036167,Carbon dioxide at 180 min,ext_bv_sbo::sbco180,30,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4m3. Carbon Dioxide (CO2) ppm at 180 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,4,0.2
http://purl.obolibrary.org/obo/EUPATH_0036180,Hydrogen at 60 min,ext_bv_sbo::sbh60,4,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4g1. Hydrogen (H2) ppm at 60 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036181,Hydrogen at 80 min,ext_bv_sbo::sbh80,5,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4h1. Hydrogen (H2) ppm at 80 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036173,Hydrogen at 100 min,ext_bv_sbo::sbh100,6,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4i1. Hydrogen (H2) ppm at 100 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036174,Hydrogen at 120 min,ext_bv_sbo::sbh120,7,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4j1. Hydrogen (H2) ppm at 120 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036175,Hydrogen at 140 min,ext_bv_sbo::sbh140,8,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4k1. Hydrogen (H2) ppm at 140 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036176,Hydrogen at 160 min,ext_bv_sbo::sbh160,9,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,4l1. Hydrogen (H2) ppm at 160 min,999.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,ppm,http://purl.obolibrary.org/obo/UO_0000169,,,,0,145,5
http://purl.obolibrary.org/obo/EUPATH_0036192,Glucose administered for breath test,ext_bv_sbo::sbglugm,,ext_bv_sbo,Glucose was administered at 5 mL/kg. Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036003,Breath test process,4c. Amount of glucose administered in  ml(5ml/kg),99:99 = Missing,variable,,,,PROVIDE Randomized Controlled Trial,,mL,http://purl.obolibrary.org/obo/UO_0000098,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036194,Hydrogen breath testing completed,ext_bv_sbo::sboutcm,,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036003,Breath test process,5a. What was the outcome of today<U+2019>s      procedure?,"1 = Procedure complete, 2 = Child ineligible due to WAZ or WHZ < -3 SD, 3 = Child unable to complete procedure, 4 = Mother or caregiver refusal to complete procedure, 5 = Procedure incomplete due to equipment failure, 6 = Procedure incomplete per PI or staff discretion,7 = Other;
9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036196,Small intestine bacterial overgrowth test date,ext_bv_sbo::sbdt,,ext_bv_sbo,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036003,Breath test process,1. Date of Procedure,9/9/99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036193,Time since last oral intake,ext_bv_sbo::sbintk,,ext_bv_sbo,Assessed at 104 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036003,Breath test process,4a. Number of hours since last oral intake (other than water),9.9 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,hours,http://purl.obolibrary.org/obo/UO_0000032,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036320,"Cryptosporidium, by qPCR",ext_lab_bv_pcrproto::crypto,,ext_lab_bv_pcrproto,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011971,Cryptosporidium in stool,Cryptosporidium,"(Positive = 1, Negative = 2, Inconclusive =3, -9 = Missing)",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036256,"Cytomegalovirus, by ELISA",ext_lab_bv_cmv::cmvreslt,,ext_lab_bv_cmv,Assessed at 40 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036029,Cytomegalovirus in blood,CMV Results,"1=Positive, 0=Negative",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010703,"Endolimax nana, by microscopy",ext_bv_dsmicr_st::enana,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011973,Endolimax in stool,10c. Endolimax Nana,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,EUPATH_0036061,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036062,"Entamoeba histolytica or dispar, by microscopy",ext_bv_dsmicr_st::micreh,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011974,Entamoeba in stool,10a. Micro Eh/Ed,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036321,"Entamoeba histolytica, by qPCR",ext_lab_bv_pcrproto::ehisto,,ext_lab_bv_pcrproto,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011974,Entamoeba in stool,Entamoeba histolytica,"(Positive = 1, Negative = 2, Inconclusive =3, -9 = Missing)",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036325,"Poliovirus, by culture",ext_lab_bv_polcul::polioc,1,ext_lab_bv_polcul,"Assessed at 6, 14, and 52 weeks using stool samples both pre- and post-polio vaccination.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036004,Enterovirus in stool,Polio  culture results,"1 = Positive (+ve to L20B cell line), 2 = Negative (-ve to both L20B and RD cell lines) , 7 = Non polio enterovirus (+ve to RD cell line, -ve to L20B cell line), 8 = Inconclusive",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036327,"Poliovirus vaccine serotype, by rRT-PCR",ext_lab_bv_polpcr::sabin,2,ext_lab_bv_polpcr,"Assessed at 6, 14, and 52 weeks using the first stool sample at each week (pre- and post-polio vaccination) positive for polio by culture.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036004,Enterovirus in stool,Sabin like (qPCR is performed  on first +ve polio culture sample in bv_polcul table),"0 = Negative, 1 = Sabin1, 2 = Sabin2, 3 = Sabin3, 4 = Sabin 1 & 2, 5 = Sabin 1 & 3, 6 = Sabin 2 & 3, 7 = Sabin 1 & 2 & 3",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036326,"Poliovirus non-vaccine serotype, by rRT-PCR",ext_lab_bv_polpcr::ns_othr,3,ext_lab_bv_polpcr,"Assessed at 6, 14, and 52 weeks using the first stool sample at each week (pre- and post-polio vaccination) positive for polio by culture.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036004,Enterovirus in stool,Non - Sabin,"1 =Non polio enterovirus,2= Pan poliovirus, 3= P1 (wild type polio strain 1),  4= P1 (wild type polio strain 2),  5= P1 (wild type polio strain 3) , 9 = Not applicable",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036328,"Poliovirus serotype Sabin 1, by multiplexed qRT-PCR",ext_lab_bv_qpcr::s1,4,ext_lab_bv_qpcr,Assessed at 6 and 52 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036004,Enterovirus in stool,Sabin1,"1=Positive, 2= Negative, - 9=Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036329,"Poliovirus serotype Sabin 2, by multiplexed qRT-PCR",ext_lab_bv_qpcr::s2,5,ext_lab_bv_qpcr,Assessed at 6 and 52 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036004,Enterovirus in stool,Sabin2,"1=Positive, 2= Negative, - 9=Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036330,"Poliovirus serotype Sabin 3, by multiplexed qRT-PCR",ext_lab_bv_qpcr::s3,6,ext_lab_bv_qpcr,Assessed at 6 and 52 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036004,Enterovirus in stool,Sabin3,"1=Positive, 2= Negative, - 9=Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036430,"Polio shedding duration, by culture",ext_mgmt_psi1_2_3_st::culdur,1,ext_mgmt_psi1_2_3_st,Assessed at 52 weeks. Based on childs last date of positive culture.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,Culture duration taken from lab_bv_polcul table - child's last date of positive culture,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036436,"Total poliovirus serotype 3 burden, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::w52_s3_si,10,ext_mgmt_psi1_2_3_st,"Mean normalized copy number x shedding duration. Assessed at 52 weeks. Uses mean of results from day 4, 11, 18, and 25 post-vaccination.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,S3_Mean_burden x S3PCRdur,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036431,"Polio serotype 1 shedding duration, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::s1pcrdur,2,ext_mgmt_psi1_2_3_st,Assessed at 52 weeks. Based on childs last date of positive culture by qPCR.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,Duration based on lab-bv_QPCR -child's last date of positive culture,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036432,"Polio serotype 2 shedding duration, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::s2pcrdur,3,ext_mgmt_psi1_2_3_st,Assessed at 52 weeks. Based on childs last date of positive culture by qPCR.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,Duration based on lab-bv_QPCR -child's last date of positive culture,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036433,"Polio serotype 3 shedding duration, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::s3pcrdur,4,ext_mgmt_psi1_2_3_st,Assessed at 52 weeks. Based on childs last date of positive culture by qPCR.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,Duration based on lab-bv_QPCR -child's last date of positive culture,,variable,,,,PROVIDE Randomized Controlled Trial,,days,http://purl.obolibrary.org/obo/UO_0000033,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036437,"Mean Poliovirus serotype 1 normalized copy number, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::s1_mean_burden,5,ext_mgmt_psi1_2_3_st,"Assessed at 52 weeks. Average of results from day 4, 11, 18, and 25 post-vaccination.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,Arithmetic Mean (of above four rows) Sabin 1 burden . Mean of variables 4-7,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036438,"Mean Poliovirus serotype 2 normalized copy number, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::s2_mean_burden,6,ext_mgmt_psi1_2_3_st,"Assessed at 52 weeks. Average of results from day 4, 11, 18, and 25 post-vaccination.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,Arithmetic Mean (of the above four rows) Sabin 2 burden. Mean of variables 4-7,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036439,"Mean Poliovirus serotype 3 normalized copy number, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::s3_mean_burden,7,ext_mgmt_psi1_2_3_st,"Assessed at 52 weeks. Average of results from day 4, 11, 18, and 25 post-vaccination.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,Arithmetic Mean (of the above four rows) Sabin 3 burden,Mean of variables 4-7,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036434,"Total poliovirus serotype 1 burden, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::w52_s1_si,8,ext_mgmt_psi1_2_3_st,"Mean normalized copy number x shedding duration. Assessed at 52 weeks. Uses mean of results from day 4, 11, 18, and 25 post-vaccination.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,S1_Mean_burden x S1PCRdur,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036435,"Total poliovirus serotype 2 burden, by multiplexed qRT-PCR",ext_mgmt_psi1_2_3_st::w52_s2_si,9,ext_mgmt_psi1_2_3_st,"Mean normalized copy number x shedding duration. Assessed at 52 weeks. Uses mean of results from day 4, 11, 18, and 25 post-vaccination.",Sample,http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,S2_mean_burden x S2PCRdur,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036063,"Escherichia coli, by microscopy",ext_bv_dsmicr_st::ecoli,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011976,Escherichia in stool,10b. Escherichia coli,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0030118,Ancylostomatoidea in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0030119,Ascaris in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036001,Blastocystis in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011971,Cryptosporidium in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011973,Endolimax in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011974,Entamoeba in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011962,Giardia in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011977,Hymenolepis in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011978,Iodamoeba in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011963,Strongyloides in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036027,Trichomonas in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0030120,Trichuris in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036064,"Giardia, by microscopy",ext_bv_dsmicr_st::giar,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011962,Giardia in stool,10g. Giardia,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036322,"Giardia, by qPCR",ext_lab_bv_pcrproto::giardia,,ext_lab_bv_pcrproto,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011962,Giardia in stool,Giardia,"(Positive = 1, Negative = 2, Inconclusive =3, -9 = Missing)",value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010730,"Hymenolepis nana, by microscopy",ext_bv_dsmicr_st::hnana,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011977,Hymenolepis in stool,11d. Hymenolepis nana,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010738,"Iodamoeba butschlii, by microscopy",ext_bv_dsmicr_st::lbuts,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011978,Iodamoeba in stool,10d. Iodamoeba butschlii,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011795,Blood test,,1,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,,11,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0002649,Blood microbiology test,,3,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036568,Stool test,,4,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011748,Stool intestinal inflammation test,,5,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000724,Stool microbiology test,,6,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,,7,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036030,Breath test,,8,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,,9,,,Sample,http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036021,Maternal blood raw antibody titer test result,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036527,"Polio serotype 1 titer, by microneutralization result",ext_lab_bv_polsna_mother_st::p1titer,,ext_lab_bv_polsna_mother_st,Assessed at 6 weeks in participant's mothers. A value less than 3 is considered seronegative.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036021,Maternal blood raw antibody titer test result,Titer Sabin 1 Log base 2 values ( <3 =seronegative ),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0036528,"Polio serotype 2 titer, by microneutralization result",ext_lab_bv_polsna_mother_st::p2titer,,ext_lab_bv_polsna_mother_st,Assessed at 6 weeks in participant's mothers.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036021,Maternal blood raw antibody titer test result,Titer Sabin 2 Log base 2 values,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0036529,"Polio serotype 3 titer, by microneutralization result",ext_lab_bv_polsna_mother_st::p3titer,,ext_lab_bv_polsna_mother_st,Assessed at 6 weeks in participant's mothers.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036021,Maternal blood raw antibody titer test result,Titer Sabin 3 Log base 2 values,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0036354,Maternal blood quantity sufficient,ext_lab_bv_speclog_mb_st::qtty,,ext_lab_bv_speclog_mb_st,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036014,Maternal blood sample,Sample sufficient or not?,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036145,Maternal blood sample collected,ext_bv_mfu_st::mcode,1,ext_bv_mfu_st,Collected at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036015,Maternal blood sample collection process,4b. Blood  (BVM-SID-66-01,1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036289,Maternal blood collection date,ext_lab_bv_speclog_mb_st::specdt | ext_lab_bv_polsna_mother_st::specdt | ext_lab_bv_cytmp::specdt,2,ext_lab_bv_cytmp | ext_lab_bv_polsna_mother_st | ext_lab_bv_speclog_mb_st,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036015,Maternal blood sample collection process,Date of Specimen Collection dd/mm/yy,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036353,Maternal blood collection comment,ext_lab_bv_speclog_mb_st::comment,3,ext_lab_bv_speclog_mb_st,Comment,Sample,http://purl.obolibrary.org/obo/EUPATH_0036015,Maternal blood sample collection process,,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036495,Granulocyte-colony stimulating factor,ext_lab_bv_cytmp::gcsf,1,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,G-CSF Conc  (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036520,Interleukin 8,ext_lab_bv_cytmp::il8,10,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-8 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036501,Interleukin 10,ext_lab_bv_cytmp::il10,11,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-10 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036503,"Interleukin 12, p70",ext_lab_bv_cytmp::il12p70,12,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-12p70 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036505,Interleukin 13,ext_lab_bv_cytmp::il13,13,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-13 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036507,Interleukin 17A,ext_lab_bv_cytmp::il17a,14,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-17A Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036524,Macrophage inflammatory protein 1 beta,ext_lab_bv_cytmp::mip1b,15,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,MIP1b Conc (pg/ml),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036522,Monocyte chemoattractant protein 1,ext_lab_bv_cytmp::mcp1,16,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,MCP-1(MCAF) Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036526,Tumor necrosis factor alpha,ext_lab_bv_cytmp::tnfa,17,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,TNFAConc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036497,Granulocyte-macrophage colony stimulating factor,ext_lab_bv_cytmp::gmcsf,2,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,GM-CSF Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036499,Interferon gamma,ext_lab_bv_cytmp::ifng,3,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IFNG Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036509,Interleukin 1 beta,ext_lab_bv_cytmp::il1b,4,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-1b Conc (pg/ml),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036533,Interleukin 2,ext_lab_bv_cytmp::il2,5,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-2 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036511,Interleukin 4,ext_lab_bv_cytmp::il4,6,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-4 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036513,Interleukin 5,ext_lab_bv_cytmp::il5,7,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-5 Conc (pg/ml),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036515,Interleukin 6,ext_lab_bv_cytmp::il6,8,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-6 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036518,Interleukin 7,ext_lab_bv_cytmp::il7,9,ext_lab_bv_cytmp,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036022,Maternal blood test,IL-7 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036018,Maternal breast milk raw antibody titer test result,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036335,"Rotavirus IgA titer, by ELISA result",ext_lab_bv_rbmiga::nortit,,ext_lab_bv_rbmiga,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036018,Maternal breast milk raw antibody titer test result,Normalized Titer (AVETIT-CONTRL),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036345,Maternal breast milk quantity sufficient,ext_lab_bv_speclog_bm_st::qtty,,ext_lab_bv_speclog_bm_st,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036017,Maternal breast milk sample,Sample sufficient or not?,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036146,Maternal breast milk sample collected,ext_bv_mfu_st::mdtm,1,ext_bv_mfu_st,Collected at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036019,Maternal breast milk sample collection process,4a. Breast Milk (BVM-SID-55-01),1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036254,Maternal breast milk sample collection date,ext_lab_bv_speclog_bm_st::specdt | ext_lab_bv_mfge8::specdt | ext_lab_bv_rbmiga::specdt | ext_lab_bv_egf::specdt | ext_lab_bv_bml_st::doc | ext_lab_bv_cytbm::specdt,2,ext_lab_bv_cytbm | ext_lab_bv_bml_st | ext_lab_bv_mfge8 | ext_lab_bv_rbmiga | ext_lab_bv_speclog_bm_st | ext_lab_bv_egf,Collected at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036019,Maternal breast milk sample collection process,Date of Specimen Collection dd/mm/yy | DOC,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036273,Eotaxin concentration,ext_lab_bv_cytbm::eotaxin,1,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Eotaxin Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036510,Interleukin 4,ext_lab_bv_cytbm::il4,10,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-4 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036512,Interleukin 5,ext_lab_bv_cytbm::il5,11,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-5 Conc (pg/ml),-9.999 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036514,Interleukin 6,ext_lab_bv_cytbm::il6,12,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-6 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036516,Interleukin 7,ext_lab_bv_cytbm::il7,13,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-7 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036519,Interleukin 8,ext_lab_bv_cytbm::il8,14,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-8 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036282,Interleukin 9,ext_lab_bv_cytbm::il9,15,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-9 Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036500,Interleukin 10,ext_lab_bv_cytbm::il10,16,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-10 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036276,"Interleukin 12, p70",ext_lab_bv_cytbm::il12p70,17,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-12p70 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036277,Interleukin 13,ext_lab_bv_cytbm::il13,18,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-13 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036278,Interleukin 15,ext_lab_bv_cytbm::il15,19,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-15 Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036292,Epidermal growth factor,ext_lab_bv_egf::egf,2,ext_lab_bv_egf,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Epidermal growth factor (EGF) pg/mL,,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036279,Interleukin 17A,ext_lab_bv_cytbm::il17a,20,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-17A Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036280,Interleukin 1 receptor agonist,ext_lab_bv_cytbm::il1ra,21,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-1ra Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036285,Macrophage inflammatory protein 1 alpha,ext_lab_bv_cytbm::mip1a,22,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,MIP-1<U+03B1> Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036523,Macrophage inflammatory protein 1 beta,ext_lab_bv_cytbm::mip1b,23,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,MIP1b Conc (pg/ml),-9.999 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036308,Milk fat globule-EGF factor 8,ext_lab_bv_mfge8::mfge8,24,ext_lab_bv_mfge8,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,MFGE8 ng/mL,,variable,,,,PROVIDE Randomized Controlled Trial,,ng/mL,http://purl.obolibrary.org/obo/UO_0000275,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036284,Monocyte chemoattractant protein 1,ext_lab_bv_cytbm::mcp1,25,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,MCP-1(MCAF) Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036286,Platelet derived growth factor,ext_lab_bv_cytbm::pdgfbb,26,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,PDGF-BB Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036287,RANTES,ext_lab_bv_cytbm::rantes,27,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Rantes Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036525,Tumor necrosis factor alpha,ext_lab_bv_cytbm::tnfa,28,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,TNFAConc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036288,Vascular endothelial growth factor,ext_lab_bv_cytbm::vegf,29,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,VEGF Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036272,Fibroblast growth factor,ext_lab_bv_cytbm::fgf,3,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Basic FGF Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036232,Capric acid (%),ext_lab_bv_bml_st::cap,30,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Capric,C10:0,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036243,Lauric acid (%),ext_lab_bv_bml_st::lau,31,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Lauric,C12:0,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036247,Myristic acid (%),ext_lab_bv_bml_st::myr,32,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Myristic,C14:0,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036251,Palmitic acid (%),ext_lab_bv_bml_st::pal,33,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Palmitic,C16:0,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036250,Palmitelaidic acid (%),ext_lab_bv_bml_st::pla,34,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Palmitelaidic,C16:1n7t,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036252,Palmitoleic acid (%),ext_lab_bv_bml_st::ple,35,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Palmitoleic,C16:1n7,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036253,Stearic acid (%),ext_lab_bv_bml_st::ste,36,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Stearic,C18:0,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036241,Elaidic acid (%),ext_lab_bv_bml_st::ela,37,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Elaidic,C18:1t,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036249,Oleic acid (%),ext_lab_bv_bml_st::ole,38,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Oleic,C18:1n9,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036245,Linoelaidic acid (%),ext_lab_bv_bml_st::lla,39,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Linoelaidic,C18:2n6t,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036274,Granulocyte-colony stimulating factor,ext_lab_bv_cytbm::gcsf,4,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,G-CSF Conc  (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036246,Linoleic acid (%),ext_lab_bv_bml_st::la,40,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Linoleic,C18:2n6,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036229,Arachidic acid (%),ext_lab_bv_bml_st::ara,41,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Arachidic,C20:0,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036242,Gamma-linolenic acid (%),ext_lab_bv_bml_st::gla,42,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,gamma-Linolenic,C18:3n6,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036240,Eicosenoic acid (%),ext_lab_bv_bml_st::eic9,43,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Eicosenoic,C20:1n9,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036530,Alpha-linolenic acid (%),ext_lab_bv_bml_st::ala,44,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Alpha-linolenic,C18:3n3,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036238,Eicosadienoic acid (%),ext_lab_bv_bml_st::eda,45,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Eicosadienoic,C20:2n6,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036231,Behenic acid (%),ext_lab_bv_bml_st::beh,46,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Behenic,C22:0,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036233,Dihomo-gamma-linolenic acid (%),ext_lab_bv_bml_st::dgla,47,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Dihomo-g-linolenic,C20:3n6,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036230,Arachidonic acid (%),ext_lab_bv_bml_st::aa,48,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Arachidonic,C20:4n6,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036244,Lignoceric acid (%),ext_lab_bv_bml_st::lig,49,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Lignoceric,C24:0,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036275,Granulocyte-macrophage colony stimulating factor,ext_lab_bv_cytbm::gmcsf,5,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,GM-CSF Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036239,Eicosapentaenoic acid (%),ext_lab_bv_bml_st::epa,50,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Eicosapentaenoic,C20:5n3,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036248,Nervonic acid (%),ext_lab_bv_bml_st::ner,51,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Nervonic,C24:1n9,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036237,Docosatetraenoic acid (%),ext_lab_bv_bml_st::dta,52,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Docosatetraenoic,C22:4n6,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036236,Docosapentaenoic acid (5n6) (%),ext_lab_bv_bml_st::dpa6,53,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Docosapentaenoic - n6,C22:5n6,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036235,Docosapentaenoic acid (5n3) (%),ext_lab_bv_bml_st::dpa,54,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Docosapentaenoic - n3,C22:5n3,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036234,Docosahexaenoic acid (%),ext_lab_bv_bml_st::dha,55,ext_lab_bv_bml_st,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,Docosahexaenoic,C22:6n3,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036498,Interferon gamma,ext_lab_bv_cytbm::ifng,6,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IFNG Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036283,Interferon gamma-induced protein 10,ext_lab_bv_cytbm::ip10,7,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IP-10 Conc (pg/mL),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036508,Interleukin 1 beta,ext_lab_bv_cytbm::il1b,8,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-1b Conc (pg/ml),-9.999 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036281,Interleukin 2,ext_lab_bv_cytbm::il2,9,ext_lab_bv_cytbm,Assessed at 6 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036020,Maternal breast milk test,IL-2 Conc (pg/ml),0.00= below detectable limit; -9=missing or not done,variable,,,,PROVIDE Randomized Controlled Trial,,pg/mL,http://purl.obolibrary.org/obo/NCIT_C67327,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036313,"Norovirus, by multiplexed qRT-PCR",ext_lab_bv_pcr::noro,,ext_lab_bv_pcr,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011980,Norovirus in stool,Norovirus using a multiplex qRT-PCR,"Positive = 1, Negative = 2, Inconclusive =3, -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036386,"Diphtheria toxoid IgG titer, by MIA result",ext_lab_bv_vac_st::dtxd,1,ext_lab_bv_vac_st,A multiplexed immuno assay was used. 0.01 IU/mL is protective. All values <0.001 IU/mL or below the standard curve were set to 0.001 IU/mL. Assessed at 53 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Diphtheria toxoid  (IU/ml),"0.01 IU/ml are considered protective / values below 0.001 IU/ml or below the standard curve for Dtxd or Ttx are set to 0.001 IU/ml, - 9 = missing",variable,,,,PROVIDE Randomized Controlled Trial,,IU/mL,http://www.ebi.ac.uk/efo/EFO_0002928,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036311,"Polio serotype 3 titer, by antibodies in lymphocyte supernatant result",ext_lab_bv_pals::titas3,10,ext_lab_bv_pals,Assessed at 6 and 40 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Titer A Sabin 3,#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011290,"Polio serotype 1 titer, by microneutralization result",ext_lab_bv_polsna_infant_st::p1titer,11,ext_lab_bv_polsna_infant_st,"Assessed at 6, 18, 40, and 53 weeks in participants. A value less than 3 is considered seronegative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Titer Sabin 1 Log base 2 values ( <3 =seronegative ),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0011291,"Polio serotype 2 titer, by microneutralization result",ext_lab_bv_polsna_infant_st::p2titer,12,ext_lab_bv_polsna_infant_st,"Assessed at 6, 18, 40, and 53 weeks in participants.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Titer Sabin 2 Log base 2 values,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0011292,"Polio serotype 3 titer, by microneutralization result",ext_lab_bv_polsna_infant_st::p3titer,13,ext_lab_bv_polsna_infant_st,"Assessed at 6, 18, 40, and 53 weeks in participants.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Titer Sabin 3 Log base 2 values,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0036443,"Adjusted polio serotype 1 titer, by microneutralization result",ext_mgmt_pso_18_st::logs18s1c,14,ext_mgmt_pso_18_st,"Participant log2 polio serotype 1 titers at 18 weeks were adjusted based on maternal antibodies at week 6, accounting for a maternal antibody half life of 28 days.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Adjusted log18s1 accounting for maternal antibodies at week 6,logs18s1c= logs18s1 - logs40s1 + (snadt18-snadt6)/28,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0036444,"Adjusted polio serotype 2 titer, by microneutralization result",ext_mgmt_pso_18_st::logs18s2c,15,ext_mgmt_pso_18_st,"Participant log2 polio serotype 1 titers at 18 weeks were adjusted based on maternal antibodies at week 6, accounting for a maternal antibody half life of 28 days.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Adjusted log18s2 accounting for maternal antibodies at week 6,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0036445,"Adjusted polio serotype 3 titer, by microneutralization result",ext_mgmt_pso_18_st::logs18s3c,16,ext_mgmt_pso_18_st,"Participant log2 polio serotype 1 titers at 18 weeks were adjusted based on maternal antibodies at week 6, accounting for a maternal antibody half life of 28 days.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Adjusted log18s3 accounting for maternal antibodies at week 6,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,log2,,,
http://purl.obolibrary.org/obo/EUPATH_0036334,"Rotavirus IgA titer, by antibodies in lymphocyte supernatant result",ext_lab_bv_rals::nortit,17,ext_lab_bv_rals,Assessed at 6 and 18 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Normalized Titer (AVETIT-CONTRL),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036490,"Rotavirus IgA titer, by ELISA result",ext_lab_bv_rpliga::nortit2,18,ext_lab_bv_rpliga,"Assessed at 6, 18, and 24 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Normalized Titer (AVETIT2-CONTRL),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011516,"Rotavirus IgA titer, by ELISA result",ext_lab_bv_rpliga::uperml2,19,ext_lab_bv_rpliga,"The rotavirus IgA titer was converted to U/mL based on a positive control. Considered seropositive if value >=20u/mL. Assessed at 6, 18, and 24 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Endpoint titer converted to units/ml for NORTIT2  [Seropositive >=20u/ml],,variable,,,,PROVIDE Randomized Controlled Trial,,U/mL,http://purl.obolibrary.org/obo/UO_0000178,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036387,"Filamentous hemagglutinin IgG titer, by MIA result",ext_lab_bv_vac_st::fha,2,ext_lab_bv_vac_st,A multiplexed immuno assay was used. Filamentous hemagglutinin (FHA) is included in pertussis vaccines. Values below 1 EU/mL or below the standard curve were set to 1 EU/mL. Assessed at 53 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Filamentous hemagglutinin (EU/ml),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,EU/mL,http://purl.obolibrary.org/obo/EUPATH_0036576,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036339,"Rotavirus IgG titer, by ELISA result",ext_lab_bv_rpligg::nortit,20,ext_lab_bv_rpligg,Assessed at 6 and 18 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Normalized Titer (AVETIT-CONTRL),-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036261,"Tetanus toxoid IgG titer, by ELISA result",ext_lab_bv_ctt::ctt,21,ext_lab_bv_ctt,Assessed at 18 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Tetanus IgG IU/ml,-9=Missing',variable,,,,PROVIDE Randomized Controlled Trial,,IU/mL,http://www.ebi.ac.uk/efo/EFO_0002928,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036388,"Haemophilus influenzae type B IgG titer, by MIA result",ext_lab_bv_vac_st::hib,3,ext_lab_bv_vac_st,A multiplexed immuno assay was used. Values >1.0 ng/mL are considered protective. All values <0.01 ng/mL or below the standard curve were set to 0.01 ng/mL. Assessed at 53 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Haemophilus influenzae type B vaccine (ng/ml),">1.0 ng/ml is considered protective;   -9= not done / all values below 0.01 ng/ml or below the standard curve for Hib are set to 0.01 ng/ml, - 9 = missing",variable,,,,PROVIDE Randomized Controlled Trial,,ng/mL,http://purl.obolibrary.org/obo/UO_0000275,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036389,"Measles IgG titer, by MIA result",ext_lab_bv_vac_st::measl,4,ext_lab_bv_vac_st,A multiplexed immuno assay was used. 0.12 IU/mL is protective. All values <0.001 IU/mL or below the standard curve were set to 0.001 IU/mL. Assessed at 53 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Measles (IU/ml),0.12 IU/ml is protective;   -9= not done / all values below 0.001 IU/ml or below the standard curve for Measles are set to 0.001 IU/ml,variable,,,,PROVIDE Randomized Controlled Trial,,IU/mL,http://www.ebi.ac.uk/efo/EFO_0002928,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036390,"Pertactin IgG titer, by MIA result",ext_lab_bv_vac_st::prn,5,ext_lab_bv_vac_st,A multiplexed immuno assay was used. Pertactin (PRN) is included in pertussis vaccines. Values below 1 EU/mL or below the standard curve were set to 1 EU/mL. Assessed at 53 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Pertactin (EU/ml),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,EU/mL,http://purl.obolibrary.org/obo/EUPATH_0036576,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036391,"Pertussis toxin IgG titer, by MIA result",ext_lab_bv_vac_st::ptx,6,ext_lab_bv_vac_st,A multiplexed immuno assay was used. Values >62.5 EU/mL are indicative for infection in the past year. Values >125 EU/mL are indicitive for recent infection. Values below 1 EU/mL or below the standard curve were set to 1 EU/mL. Assessed at 53 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Vaccine response to B. Pertussis toxin (EU/ml),levels >62.5 LU/ml indicative for infection in the past year ; levels over 125 LU/ml for recent infection;   -9= not done / values below 1 EU/ml or below the standard curve are set to 1 EU/ml for all pertussis antigens,variable,,,,PROVIDE Randomized Controlled Trial,,EU/mL,http://purl.obolibrary.org/obo/EUPATH_0036576,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036392,"Tetanus toxoid IgG titer, by MIA result",ext_lab_bv_vac_st::ttx,7,ext_lab_bv_vac_st,A multiplexed immuno assay was used. 0.01 IU/mL is protective. All values <0.001 IU/mL or below the standard curve were set to 0.001 IU/mL. Assessed at 53 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Tetanus toxin (IU/ml),"0.01 IU/ml are considered protective;   -9= not done / values below 0.001 IU/ml or below the standard curve for Dtxd or Ttx are set to 0.001 IU/ml, - 9 = missing",variable,,,,PROVIDE Randomized Controlled Trial,,IU/mL,http://www.ebi.ac.uk/efo/EFO_0002928,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036309,"Polio serotype 1 titer, by antibodies in lymphocyte supernatant result",ext_lab_bv_pals::titas1,8,ext_lab_bv_pals,Assessed at 6 and 40 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Titer A Sabin 1,#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036310,"Polio serotype 2 titer, by antibodies in lymphocyte supernatant result",ext_lab_bv_pals::titas2,9,ext_lab_bv_pals,Assessed at 6 and 40 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011472,Raw antibody titer test result,Titer A Sabin 2,#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036358,"16S ribosomal, by TAC result",ext_lab_bv_tac::16s | ext_lab_bv_tacd::16s,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,16S,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015332,Aeromonas by TAC result,ext_lab_bv_tacd::aero | ext_lab_bv_tac::aero,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,Aeromonas,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015337,"Bacteroides fragilis, by TAC result",ext_lab_bv_tacd::bfragi | ext_lab_bv_tac::bfragi,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,B.fragilis,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015341,"Campylobacter jejuni or C. coli, by TAC result",ext_lab_bv_tac::cjeju | ext_lab_bv_tacd::cjeju,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,C.jejuni/coli,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015338,"Campylobacter, by TAC result",ext_lab_bv_tacd::campy | ext_lab_bv_tac::campy,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,Campy pan,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0011855,"Clostridium difficile, by TAC result",ext_lab_bv_tac::cdiffic | ext_lab_bv_tacd::cdiffic,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,C.difficile,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015346,"EAEC aaiC, by TAC result",ext_lab_bv_tacd::eaecic | ext_lab_bv_tac::eaecic,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,EAEC_aaiC,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015348,"EAEC aatA, by TAC result",ext_lab_bv_tac::eaecat | ext_lab_bv_tacd::eaecat,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,EAEC_aatA,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015349,"EAEC aggR, by TAC result",ext_lab_bv_tacd::eaecag,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,EAEC_aggR,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0011892,"EAEC aggR-activated regulator (aar), by TAC result",ext_lab_bv_tacd::eaecar,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,EAEC_aar,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015353,"EPEC bfpA, by TAC result",ext_lab_bv_tacd::epecbf | ext_lab_bv_tac::epecbf,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,EPEC_bfpA,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0011857,"EPEC eae, by TAC result",ext_lab_bv_tac::epecea | ext_lab_bv_tacd::epecea,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,EPEC_eae,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015355,"ETEC LT-pos, by TAC result",ext_lab_bv_tac::eteclt | ext_lab_bv_tacd::eteclt,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,ETEC_LT,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015356,"ETEC STh, by TAC result",ext_lab_bv_tacd::etecsth | ext_lab_bv_tac::etecsth,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,ETEC_STh,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015357,"ETEC STp, by TAC result",ext_lab_bv_tacd::etecstp | ext_lab_bv_tac::etecstp,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,ETEC_STp,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015361,"Helicobacter pylori, by TAC result",ext_lab_bv_tacd::hpylo | ext_lab_bv_tac::hpylo,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,H.pylori,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0011865,"Mycobacterium tuberculosis, by TAC result",ext_lab_bv_tacd::mtb | ext_lab_bv_tac::mtb,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,M.tb,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015384,"STEC stx1, by TAC result",ext_lab_bv_tac::stecst1 | ext_lab_bv_tacd::stecst1,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,STEC_stx1,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015385,"STEC stx2, by TAC result",ext_lab_bv_tacd::stecst2 | ext_lab_bv_tac::stecst2,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,STEC_stx2,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015381,"Salmonella, by TAC result",ext_lab_bv_tacd::salmo | ext_lab_bv_tac::salmo,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,Salmonella,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015383,"Shigella or EIEC, by TAC result",ext_lab_bv_tac::eiecsh | ext_lab_bv_tacd::eiecsh,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,EIEC/Shigella,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015388,"Vibrio cholerae, by TAC result",ext_lab_bv_tacd::vchol | ext_lab_bv_tac::vchol,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,V.cholerae,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015333,"Ancylostoma, by TAC result",ext_lab_bv_tac::ancyc | ext_lab_bv_tacd::ancyc,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Ancyclostoma,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015334,"Ascaris, by TAC result",ext_lab_bv_tac::al | ext_lab_bv_tacd::al,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Ascaris,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015343,"Cryptosporidium hominis, by TAC result",ext_lab_bv_tacd::cryphom | ext_lab_bv_tac::cryphom,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Crypto_Lib hominis,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015344,"Cryptosporidium parvum, by TAC result",ext_lab_bv_tacd::cryppar | ext_lab_bv_tac::cryppar,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Crypto_lib parvum,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015342,"Cryptosporidium, by TAC result",ext_lab_bv_tacd::cryp | ext_lab_bv_tac::cryp,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Cryptosporidium,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036531,"Cryptosporidium, by qPCR result",ext_lab_bv_pcrproto::crypct,,ext_lab_bv_pcrproto,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Cryptosporidium Ct Value,(-9 = Missing),variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015345,"Cyclospora, by TAC result",ext_lab_bv_tacd::cyclo | ext_lab_bv_tac::cyclo,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Cyclospora,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015352,"Encephalitozoon intestinalis, by TAC result",ext_lab_bv_tacd::eint | ext_lab_bv_tac::eint,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,E.intestinalis,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015351,"Entamoeba histolytica, by TAC result",ext_lab_bv_tac::eh | ext_lab_bv_tacd::eh,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,E.histolytica,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036323,"Entamoeba histolytica, by qPCR result",ext_lab_bv_pcrproto::ehisct,,ext_lab_bv_pcrproto,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Entamoeba histolytica Ct Value,(-9 = Missing),variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015350,"Enterocytozoon bieneusi, by TAC result",ext_lab_bv_tac::ebien | ext_lab_bv_tacd::ebien,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,E.bieneusi,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036361,"Eukaryotic 18S rRNA endogenous control, by TAC result",ext_lab_bv_tacd::hs99s1 | ext_lab_bv_tac::hs99s1,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Hs99999901_s1,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015358,"Giardia assemblage A, by TAC result",ext_lab_bv_tacd::giarta | ext_lab_bv_tac::giarta,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Giardia TPI A,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015359,"Giardia assemblage B, by TAC result",ext_lab_bv_tac::giartb | ext_lab_bv_tacd::giartb,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Giardia TPI B,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015360,"Giardia, by TAC result",ext_lab_bv_tacd::giar | ext_lab_bv_tac::giar,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,10g. Giardia,1=Yes;     2=No,variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036324,"Giardia, by qPCR result",ext_lab_bv_pcrproto::giact,,ext_lab_bv_pcrproto,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Giardia Ct Value,(-9 = Missing),variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015362,"Isospora, by TAC result",ext_lab_bv_tacd::isospo | ext_lab_bv_tac::isospo,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Isospora,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015363,"Necator, by TAC result",ext_lab_bv_tacd::necato | ext_lab_bv_tac::necato,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Necator,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015386,"Strongyloides, by TAC result",ext_lab_bv_tacd::strongy | ext_lab_bv_tac::strongy,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Strongyloides,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015387,"Trichuris trichiura, by TAC result",ext_lab_bv_tacd::tt | ext_lab_bv_tac::tt,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,Trichuris trichiura,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0011843,Raw bacteria data for stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0010985,Raw test result for stool,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011845,Raw eukaryota data for stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0010985,Raw test result for stool,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0010985,Raw test result for stool,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0015331,"Adenovirus 40/41, by TAC result",ext_lab_bv_tac::aden4041 | ext_lab_bv_tacd::adeno40,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Adenovirus F | Adenovirus 40/41,"0=Negative,  >0 & < 35=Positive,  -9 = Missing | 35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015330,"Adenovirus, by TAC result",ext_lab_bv_tac::adenopan | ext_lab_bv_tacd::adeno,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Adenovirus | Adenovirus Pan,"0=Negative,  >0 & < 35=Positive,  -9 = Missing | 35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015335,"Astrovirus, by TAC result",ext_lab_bv_tacd::astro | ext_lab_bv_tac::astro,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Astrovirus,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036316,"Astrovirus, by qPCR result",ext_lab_bv_pcr::astct,,ext_lab_bv_pcr,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Astro Ct Value,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036257,"Cytomegalovirus, by qPCR result",ext_lab_bv_cmvrt::cmv_ct,,ext_lab_bv_cmvrt,Value >0 and <= 35 considered CMV positive. Assessed at 6 and 10 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Positive result defined by validated cutoff of ct 35. Ct. Value >0 and < or = 35 considered  CMV +,#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036359,"Enterobacteria phage MS2, by TAC result",ext_lab_bv_tac::ms2 | ext_lab_bv_tacd::ms2,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,MS2,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036360,"Enterovirus, by TAC result",ext_lab_bv_tac::entero | ext_lab_bv_tacd::entero,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Enterovirus,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015364,"Norovirus GI, by TAC result",ext_lab_bv_tac::norog1 | ext_lab_bv_tacd::norog1,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Norovirus GI,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015365,"Norovirus GII, by TAC result",ext_lab_bv_tac::norog2 | ext_lab_bv_tacd::norog2,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Norovirus GII,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0010781,"Norovirus, by qRT-PCR result",ext_lab_bv_pcr::norct,,ext_lab_bv_pcr,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Noro Ct Value,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036369,"Oral poliovirus vaccine type 1, by TAC result",ext_lab_bv_tacd::opv1,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,OPV1,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036370,"Oral poliovirus vaccine type 2, by TAC result",ext_lab_bv_tacd::opv2,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,OPV2,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036371,"Oral poliovirus vaccine type 3, by TAC result",ext_lab_bv_tacd::opv3,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,OPV3,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036363,"Phocine herpesvirus (positive control), by TAC result",ext_lab_bv_tacd::phhv | ext_lab_bv_tac::phhv,,ext_lab_bv_tacd | ext_lab_bv_tac,"Phocine herpes virus was spiked into every stool sample to control for extraction and amplification. Failure indicates that the sample was either inhibited, amplification failed, and/or extraction failed. For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,PhHV,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036440,"Poliovirus serotype 1 normalized copy number, by multiplexed qRT-PCR result",ext_mgmt_psi1_2_3_st::s1adj1g,,ext_mgmt_psi1_2_3_st,Assessed at 52 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Week 52 Day 4 adjusted copy number for sabin1*,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036331,"Poliovirus serotype 1, by multiplexed qRT-PCR result",ext_lab_bv_qpcr::s1ct,,ext_lab_bv_qpcr,Assessed at 6 and 52 weeks. Considered positive if 0 < Ct value < 36.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Sabin1 CT Value (CT values >0 and < 36 = Positive),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036441,"Poliovirus serotype 2 normalized copy number, by multiplexed qRT-PCR result",ext_mgmt_psi1_2_3_st::s2adj1g,,ext_mgmt_psi1_2_3_st,Assessed at 52 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Week 52 Day 4 adjusted copy number for sabin2*,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036332,"Poliovirus serotype 2, by multiplexed qRT-PCR result",ext_lab_bv_qpcr::s2ct,,ext_lab_bv_qpcr,Assessed at 6 and 52 weeks. Considered positive if 0 < Ct value < 37.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Sabin2 CT Value (CT values >0 and < 37 = Positive),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036442,"Poliovirus serotype 3 normalized copy number, by multiplexed qRT-PCR result",ext_mgmt_psi1_2_3_st::s3adj1g,,ext_mgmt_psi1_2_3_st,Assessed at 52 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Week 52 Day 4 adjusted copy number for sabin3*,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036333,"Poliovirus serotype 3, by multiplexed qRT-PCR result",ext_lab_bv_qpcr::s3ct,,ext_lab_bv_qpcr,Assessed at 6 and 52 weeks. Considered positive if 0 < Ct value < 37.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Sabin3 CT Value (CT values >0 and < 37 = Positive),#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036290,"Rotavirus G genotype, by qRT-PCR result",ext_lab_bv_dsgene::rotag,,ext_lab_bv_dsgene,"Diarrheal samples positive for rotavirus by both ELISA and TAC assays or just TAC were genotyped using two real time RT-PCR panels; Panel G- G1, G2, G9, G12, NSP3; Panel P-P4, P6, P8, P10, P11. 158 samples were positive by both ELISA and TAC, and 105 samples were positive by only TAC.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,G Type Gene Sequence for Rotavirus positive strain using a RT-PCR,"1 = G type 1, 2 = G type 2, 9 = G type 9, 12 = G type 12, 3 = Mixed, 0 = unable to type (-9 = missing data)",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036291,"Rotavirus P genotype, by qRT-PCR result",ext_lab_bv_dsgene::rotap,,ext_lab_bv_dsgene,"Diarrheal samples positive for rotavirus by both ELISA and TAC assays or just TAC were genotyped using two real time RT-PCR panels; Panel G- G1, G2, G9, G12, NSP3; Panel P-P4, P6, P8, P10, P11. 158 samples were positive by both ELISA and TAC, and 105 samples were positive by only TAC.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,P Type Gene Sequence for Rotavirus positive strain using a RT-PCR,"4 = P type 4, 6 = P type 6, 8 = P type 8, 10 = P type 10, 11 = P type 11, 3 = Mixed, 0 = unable to type (-9 = missing data)",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0015369,"Rotavirus genotype G1, by TAC result",ext_lab_bv_tacd::rotag1,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus G1,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015367,"Rotavirus genotype G10, by TAC result",ext_lab_bv_tacd::rotag10,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus G10,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015368,"Rotavirus genotype G12, by TAC result",ext_lab_bv_tacd::rotag12,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus G12,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015370,"Rotavirus genotype G2, by TAC result",ext_lab_bv_tacd::rotag2,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus G2,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015371,"Rotavirus genotype G3, by TAC result",ext_lab_bv_tacd::rotag3,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus G3,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015372,"Rotavirus genotype G4, by TAC result",ext_lab_bv_tacd::rotag4,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus G4,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015373,"Rotavirus genotype G8, by TAC result",ext_lab_bv_tacd::rotag8,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus G8,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015374,"Rotavirus genotype G9, by TAC result",ext_lab_bv_tacd::rotag9,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus G9,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015375,"Rotavirus genotype P10, by TAC result",ext_lab_bv_tacd::rotap10,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus P10,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015376,"Rotavirus genotype P11, by TAC result",ext_lab_bv_tacd::rotap11,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus P11,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015377,"Rotavirus genotype P4, by TAC result",ext_lab_bv_tacd::rotap4,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus P4,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015378,"Rotavirus genotype P6, by TAC result",ext_lab_bv_tacd::rotap6,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus P6,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015379,"Rotavirus genotype P8, by TAC result",ext_lab_bv_tacd::rotap8,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus P8,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015380,"Rotavirus genotype P9, by TAC result",ext_lab_bv_tacd::rotap9,,ext_lab_bv_tacd,"For diarrheal stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus P9,"35 = no detection,  >0 & < 35 =Positive,  -9 = NA",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015366,"Rotavirus, by TAC result",ext_lab_bv_tac::rota | ext_lab_bv_tacd::rota,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rotavirus,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036318,"Rotavirus, by qPCR result",ext_lab_bv_pcr::rotact,,ext_lab_bv_pcr,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Rota Ct Value,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0015382,"Sapovirus, by TAC result",ext_lab_bv_tac::sapo | ext_lab_bv_tacd::sapo,,ext_lab_bv_tacd | ext_lab_bv_tac,"For diarrheal stool samples, but not week 6 or week 10 stool samples, Ct values >= 35 are displayed as 35. Ct values of >= 35 are considered negative.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Sapovirus,"0=Negative,  >0 & < 35=Positive,  -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0036319,"Sapovirus, by qPCR result",ext_lab_bv_pcr::sapct,,ext_lab_bv_pcr,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011844,Raw virus data for stool,Sapo Ct Value,-9 = Missing',variable,,,,PROVIDE Randomized Controlled Trial,,Ct value,http://purl.obolibrary.org/obo/EUPATH_0015721,,,,0,45,1
http://purl.obolibrary.org/obo/EUPATH_0010793,"Rotavirus, by ELISA",ext_mgmt_bv_ddep_st::rotads | ext_lab_bv_rotavs::rotavs,,ext_mgmt_bv_ddep_st | ext_lab_bv_rotavs,Assessed at 10 and 17 weeks.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011982,Rotavirus in stool,Rotavirus by ELISA | Rotavirus in diarrheal stool by ELISA,"1=Positive, 2=Negative 2, 3=Inconclusive , -9 = Missing | 1= Positive, 2= Negative,  3= Inconclusive, -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036314,"Rotavirus, by qPCR",ext_lab_bv_pcr::rota,,ext_lab_bv_pcr,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011982,Rotavirus in stool,Rotavirus,"Positive = 1, Negative = 2, Inconclusive: Ct value ¬¨‚â• 36 = 3, -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036350,Saliva quantity sufficient,ext_lab_bv_speclog_is_st::qtty,,ext_lab_bv_speclog_is_st,,Sample,http://purl.obolibrary.org/obo/OBI_0002507,Saliva sample,Sample sufficient or not?,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036112,Saliva collected,ext_bv_f53::f53slv | ext_bv_f104::f104slv,1,ext_bv_f104 | ext_bv_f53,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036026,Saliva sample collection process,6c. Saliva (BVC-SID-77-01) | 7d. Saliva (BVC-SID-77-02),1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036349,Saliva collection date,ext_lab_bv_speclog_is_st::specdt,2,ext_lab_bv_speclog_is_st,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036026,Saliva sample collection process,Date of Specimen Collection dd/mm/yy,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000056,Laboratory test,,1,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000659,Sample collection,,2,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000655,Blood sample,,3,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0002503,Stool sample,,4,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000651,Urine sample,,5,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0002507,Saliva sample,,6,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036014,Maternal blood sample,,7,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036017,Maternal breast milk sample,,8,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000609,Sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011482,Blood sample collection process,,1,,,Sample,http://purl.obolibrary.org/obo/OBI_0000659,Sample collection,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010039,Stool sample collection process,,2,,,Sample,http://purl.obolibrary.org/obo/OBI_0000659,Sample collection,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011473,Urine sample collection process,,3,,,Sample,http://purl.obolibrary.org/obo/OBI_0000659,Sample collection,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036003,Breath test process,,4,,,Sample,http://purl.obolibrary.org/obo/OBI_0000659,Sample collection,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036026,Saliva sample collection process,,5,,,Sample,http://purl.obolibrary.org/obo/OBI_0000659,Sample collection,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036015,Maternal blood sample collection process,,6,,,Sample,http://purl.obolibrary.org/obo/OBI_0000659,Sample collection,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036019,Maternal breast milk sample collection process,,7,,,Sample,http://purl.obolibrary.org/obo/OBI_0000659,Sample collection,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036315,"Sapovirus, by qPCR",ext_lab_bv_pcr::sapo,,ext_lab_bv_pcr,,Sample,http://purl.obolibrary.org/obo/EUPATH_0015713,Sapovirus in stool,Sapovirus,"Positive = 1, Negative = 2, Inconclusive =3, -9 = Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010217,Stool consistency,ext_bv_dsmicr_st::cons,1,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0010038,Stool characteristics,3. Consistency,1=Normal; 2=Loose;3=Liquid;4=Watery,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0015217,Stool blood present,ext_bv_dsmicr_st::bld,2,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0010038,Stool characteristics,4. Blood,0=None;1=Trace;2=Moderate ;3=Heavy,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0000711,Stool mucus present,ext_bv_dsmicr_st::mucus,3,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0010038,Stool characteristics,5. Mucus,0=None; 1=Trace; 2=Moderate ;3=Heavy,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011276,Alpha-1-antitrypsin,ext_lab_bv_ala::ala,,ext_lab_bv_ala,"Assessed at 12, 24, and 40 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011748,Stool intestinal inflammation test,Alpha-1- anti trypsin result mg/g,'-9 = Missing,variable,,,,PROVIDE Randomized Controlled Trial,,mg/g,http://purl.obolibrary.org/obo/EUPATH_0036574,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036255,Calprotectin,ext_lab_bv_calp::calp,,ext_lab_bv_calp,"Assessed at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011748,Stool intestinal inflammation test,Calprotectin result ug/g,'-9 = Missing,variable,,,,PROVIDE Randomized Controlled Trial,,ug/g,http://purl.obolibrary.org/obo/EUPATH_0036575,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011277,Myeloperoxidase,ext_lab_bv_mpo::mpo,,ext_lab_bv_mpo,"Assessed at 12, 24, and 40 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011748,Stool intestinal inflammation test,Myeloperoxidase result ng/ml,‚àö√§'-9 = Missing,variable,,,,PROVIDE Randomized Controlled Trial,,ng/mL,http://purl.obolibrary.org/obo/UO_0000275,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011278,Neopterin,ext_lab_bv_neop::neop,,ext_lab_bv_neop,"Assessed at 12, 24, and 40 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011748,Stool intestinal inflammation test,Neopterin result nmol/L,‚àö√§-9 = Missing,variable,,,,PROVIDE Randomized Controlled Trial,,nmol/L,http://purl.obolibrary.org/obo/EUPATH_0036573,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036337,Regenerating family member 1 beta,ext_lab_bv_reg1b_upd1::reg1b,,ext_lab_bv_reg1b_upd1,"REG1B concentration in stool was assessed at 6, 12, 18, 24, 40, 52, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011748,Stool intestinal inflammation test,Reg 1 B result ug/ml,‚àö√§-9 = Missing,variable,,,,PROVIDE Randomized Controlled Trial,,ug/mL,http://purl.obolibrary.org/obo/UO_0000274,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036071,"Any pathogen, by microscopy",ext_bv_dsmicr_st::status,1,ext_bv_dsmicr_st,"Any helminth, single cell parasites, or E. coli identified by microscopy. Assessed once per diarrheal episode.",Sample,http://purl.obolibrary.org/obo/EUPATH_0000724,Stool microbiology test,9. Status,0=No; 1=Yes,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011967,Bacteria in stool,,2,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000724,Stool microbiology test,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0030117,Eukaryota in stool,,3,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000724,Stool microbiology test,,,multifilter,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011959,Virus in stool,,4,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000724,Stool microbiology test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010985,Raw test result for stool,,5,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000724,Stool microbiology test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0030114,Aggregate organism in stool detection data,,6,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000724,Stool microbiology test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011800,Stool microbiology test procedures,,7,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0000724,Stool microbiology test,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011785,Stool virus testing,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011800,Stool microbiology test procedures,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010558,Quantity not sufficient,ext_lab_bv_speclog_vsr_st::qtty | ext_lab_bv_speclog_ds_st::qtty | ext_lab_bv_speclog_fc_st::qtty | ext_lab_bv_speclog_cs_st::qtty | ext_lab_bv_speclog_vsp_st::qtty,,ext_lab_bv_speclog_vsp_st | ext_lab_bv_speclog_ds_st | ext_lab_bv_speclog_vsr_st | ext_lab_bv_speclog_cs_st | ext_lab_bv_speclog_fc_st,,Sample,http://purl.obolibrary.org/obo/OBI_0002503,Stool sample,Sample sufficient or not?,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010038,Stool characteristics,,,,,Sample,http://purl.obolibrary.org/obo/OBI_0002503,Stool sample,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010869,Stool type,ext_lab_bv_rotavs::spectype | ext_lab_bv_ala::spectype | ext_lab_bv_speclog_fc_st::spectype | ext_lab_bv_qpcr::spectype | ext_lab_bv_dsgene::spectype | ext_lab_bv_speclog_ds_st::spectype | ext_lab_bv_speclog_cs_st::spectype | ext_lab_bv_reg1b_upd1::spectype | ext_lab_bv_speclog_vsr_st::spectype | ext_lab_bv_tacd::spectype | ext_lab_bv_tac::spectype | ext_lab_bv_mpo::spectype | ext_lab_bv_speclog_vsp_st::spectype | ext_lab_bv_polcul::spectype | ext_lab_bv_cmvrt::spectype | ext_lab_bv_pcr::spectype | ext_lab_bv_calp::spectype | ext_lab_bv_neop::spectype | ext_lab_bv_pcrproto::spectype | ext_lab_bv_polpcr::spectype,,ext_lab_bv_pcr | ext_lab_bv_tacd | ext_lab_bv_tac | ext_lab_bv_polcul | ext_lab_bv_pcrproto | ext_lab_bv_neop | ext_lab_bv_qpcr | ext_lab_bv_dsgene | ext_lab_bv_speclog_vsp_st | ext_lab_bv_speclog_ds_st | ext_lab_bv_speclog_vsr_st | ext_lab_bv_speclog_cs_st | ext_lab_bv_speclog_fc_st | ext_lab_bv_polpcr | ext_lab_bv_mpo | ext_lab_bv_rotavs | ext_lab_bv_cmvrt | ext_lab_bv_calp | ext_lab_bv_ala | ext_lab_bv_reg1b_upd1,,Sample,http://purl.obolibrary.org/obo/OBI_0002503,Stool sample,Specimen type,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0041019,Stool collected,ext_bv_f53::f53stl | ext_bv_f39::f39stl | ext_bv_rss_st::stl | ext_bv_fcs_st::stl | ext_bv_f40::f40stl | ext_bv_fan::fanstl | ext_bv_f18::f18stl | ext_bv_ps1_2_st::stl | ext_bv_f06::f6stl | ext_bv_f10::f10stl | ext_bv_flm::flmstl | ext_mgmt_bv_ddep_st::specyes | ext_bv_f104::f104stl | ext_mgmt_bv_mib_st::bsto,1,ext_bv_flm | ext_bv_f104 | ext_bv_f53 | ext_bv_f18 | ext_bv_f06 | ext_bv_f40 | ext_mgmt_bv_ddep_st | ext_bv_f39 | ext_bv_f10 | ext_bv_fan | ext_bv_fcs_st | ext_mgmt_bv_mib_st | ext_bv_ps1_2_st | ext_bv_rss_st,,Sample,http://purl.obolibrary.org/obo/EUPATH_0010039,Stool sample collection process,7b. Clinic Visit Stool (BVC-SID-10-02) | 10. Baseline stool collected | 7b. Clinic Visit Stool Week 12 specimen BVC-SID-10-04 OR Week 24 specimen BVC-SID-10-08 | Whether stool specimen collected or not | 6a. Clinic Visit Stool  (BVC-SID-10-14) OR (BVC-SID-10-15) OR (BVC-SID-10-16) | Stool collected? | 6b. Clinic Visit Stool  (BVC-SID-10-12) | 7b. Clinic Visit Stool  (BVC-SID-10-10) | 7b. Clinic Visit Stool  (BVC-SID-10-13) | 6a. Clinic Visit Stool (BVC-SID-10-03) | 6b. Clinic Visit Stool  (BVC-SID-10-07) | 6a. Clinic Visit Stool (BVC-SID-10-09),"1=Yes; 2=No | 1=Yes, 2=No, -9=NA | 1=Yes; 2=No; 9=Missing",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036072,Stool collection date,ext_lab_bv_polcul::specdt | ext_mgmt_bv_ddep_st::specdt | ext_lab_bv_pcrproto::specdt | ext_bv_dsmicr_st::specdt | ext_bv_fcs_st::specdt | ext_lab_bv_speclog_fc_st::specdt | ext_lab_bv_ala::specdt | ext_lab_bv_qpcr::specdt | ext_lab_bv_speclog_ds_st::specdt | ext_lab_bv_reg1b_upd1::specdt | ext_lab_bv_speclog_cs_st::specdt | ext_lab_bv_rotavs::specdt | ext_lab_bv_speclog_vsr_st::specdt | ext_lab_bv_dsgene::specdt | ext_lab_bv_speclog_vsp_st::specdt | ext_lab_bv_tac::specdt | ext_lab_bv_neop::specdt | ext_lab_bv_tacd::specdt | ext_bv_rss_st::specdt | ext_bv_ps1_2_st::specdt | ext_mgmt_bv_mib_st::stdt | ext_lab_bv_mpo::specdt | ext_lab_bv_calp::specdt | ext_lab_bv_cmvrt::specdt | ext_mgmt_psi1_2_3_st::specdt | ext_lab_bv_polpcr::specdt | ext_lab_bv_pcr::specdt,2,ext_lab_bv_pcr | ext_bv_dsmicr_st | ext_bv_fcs_st | ext_mgmt_bv_mib_st | ext_bv_ps1_2_st | ext_bv_rss_st | ext_lab_bv_tacd | ext_lab_bv_tac | ext_lab_bv_polcul | ext_mgmt_psi1_2_3_st | ext_lab_bv_pcrproto | ext_lab_bv_neop | ext_lab_bv_qpcr | ext_lab_bv_dsgene | ext_lab_bv_speclog_vsp_st | ext_lab_bv_speclog_ds_st | ext_lab_bv_speclog_vsr_st | ext_lab_bv_speclog_cs_st | ext_lab_bv_speclog_fc_st | ext_lab_bv_polpcr | ext_lab_bv_mpo | ext_lab_bv_rotavs | ext_lab_bv_cmvrt | ext_lab_bv_calp | ext_lab_bv_ala | ext_lab_bv_reg1b_upd1,,Sample,http://purl.obolibrary.org/obo/EUPATH_0010039,Stool sample collection process,"Date of Specimen Collection dd/mm/yy | 2a. If yes, date of stool collection | If yes, date of stool collection | Date of stool collection (within 96 hours of enrollment",1=Yes; 2=No; 9=Missing | 9/9/1999 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036143,Stool timeline,ext_bv_rss_st::vstdetail | ext_bv_ps1_2_st::vstdetail | ext_lab_bv_rotavs::vstdetail | ext_lab_bv_qpcr::vstdetail | ext_lab_bv_speclog_fc_st::vstdetail | ext_lab_bv_polpcr::vstdetail | ext_lab_bv_polcul::vstdetail | ext_lab_bv_speclog_vsp_st::vstdetail | ext_bv_fcs_st::vstdetail | ext_lab_bv_speclog_vsr_st::vstdetail,3,ext_bv_fcs_st | ext_bv_ps1_2_st | ext_bv_rss_st | ext_lab_bv_polcul | ext_lab_bv_qpcr | ext_lab_bv_speclog_vsp_st | ext_lab_bv_speclog_vsr_st | ext_lab_bv_speclog_fc_st | ext_lab_bv_polpcr | ext_lab_bv_rotavs,,Sample,http://purl.obolibrary.org/obo/EUPATH_0010039,Stool sample collection process,1. Rotavirus Shedding stool collection time point | 1. Polio Shedding stool collection time point | visit details | Visit details,1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036346,Stool collection comment,ext_lab_bv_speclog_fc_st::comment | ext_lab_bv_speclog_cs_st::comment | ext_lab_bv_speclog_ds_st::comment | ext_lab_bv_speclog_vsr_st::comment | ext_lab_bv_speclog_vsp_st::comment,4,ext_lab_bv_speclog_vsp_st | ext_lab_bv_speclog_ds_st | ext_lab_bv_speclog_vsr_st | ext_lab_bv_speclog_cs_st | ext_lab_bv_speclog_fc_st,Comment,Sample,http://purl.obolibrary.org/obo/EUPATH_0010039,Stool sample collection process,,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036058,Red blood cell count,ext_bv_dsmicr_st::rbc,1,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036568,Stool test,6. RBC,1=0; 2=1-10;3=11-20;4=21-50; 5=>50,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036057,Pus cell count,ext_bv_dsmicr_st::pus,2,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036568,Stool test,7. Pus cell,1=0; 2=1-10; 3=11-20; 4=21-50; 5=>50,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036056,Macrophage count,ext_bv_dsmicr_st::macro,3,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036568,Stool test,8. Macrophages,1=0;  2=1-10; 3=11-20; 4=21-50; 5=>50,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010581,Rotavirus ELISA performed,ext_mgmt_bv_ddep_st::epistool,,ext_mgmt_bv_ddep_st,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011785,Stool virus testing,Episode stool collected **Variable to indicate the stool collection from both clinical (bv_dir) and lab (lab_bv_rotads) data tables,"1= Yes, -9= Not applicable; NA=Not available",variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010809,"Strongyloides stercoralis, by microscopy",ext_bv_dsmicr_st::ss,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0011963,Strongyloides in stool,11e. Strongyloides stercoralis,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036069,"Trichomonas hominis, by microscopy",ext_bv_dsmicr_st::thomi,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0036027,Trichomonas in stool,10f. Trichomonas hominis,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0010615,"Trichuris trichiura, by microscopy",ext_bv_dsmicr_st::tt,,ext_bv_dsmicr_st,Assessed once per diarrheal episode.,Sample,http://purl.obolibrary.org/obo/EUPATH_0030120,Trichuris in stool,Trichuris trichiura,1=Yes;     2=No,value,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036352,Urine quantity sufficient,ext_lab_bv_speclog_iu_st::qtty,,ext_lab_bv_speclog_iu_st,,Sample,http://purl.obolibrary.org/obo/OBI_0000651,Urine sample,Sample sufficient or not?,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011194,Urine volume,ext_bv_f104::f104ml | ext_bv_f40::f40ml | ext_bv_flm::flmml,,ext_bv_flm | ext_bv_f104 | ext_bv_f40,"Collected at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/OBI_0000651,Urine sample,6d. Total L/M urine volume (ml) | 5d. Total L/M urine volume (ml),999 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,mL,http://purl.obolibrary.org/obo/UO_0000098,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0033265,Urine collected,ext_bv_f104::f104ur | ext_bv_flm::flmur | ext_bv_f40::f40ur,1,ext_bv_flm | ext_bv_f104 | ext_bv_f40,"Collected at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011473,Urine sample collection process,7a. L/M Urine  (BVC-SID-44-04) | 7a. L/M Urine (BVC-SID-44-03) | 7a. L/M Urine Week 12 specimen BVC-SID-44-01  OR Week 24 specimen BVC-SID-44-02,1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0033266,Urine collection date,ext_lab_bv_speclog_iu_st::specdt | ext_mgmt_bv_lmratio::lmdoc,2,ext_lab_bv_speclog_iu_st | ext_mgmt_bv_lmratio,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011473,Urine sample collection process,Date of Specimen Collection dd/mm/yy | Date of visit,9/9/99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036115,Urine collection start time,ext_bv_f104::f104st | ext_bv_f40::f40st | ext_bv_flm::flmst,3,ext_bv_flm | ext_bv_f104 | ext_bv_f40,"Done at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011473,Urine sample collection process,5b. Start time of testing (time administration completed) | 6b. Start time of testing (time administration completed),,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036114,Urine collection end time,ext_bv_flm::flmet | ext_bv_f40::f40et | ext_bv_f104::f104et,4,ext_bv_flm | ext_bv_f104 | ext_bv_f40,"Done at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011473,Urine sample collection process,6c. End time of L/M urine collection | 5c. End time of L/M urine collection,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036116,Urine stored with preservative,ext_bv_f40::f40pr | ext_bv_f104::f104pr | ext_bv_flm::flmpr,5,ext_bv_flm | ext_bv_f104 | ext_bv_f40,10-15 mL aliquot of L/M urine was stored with preservative,Sample,http://purl.obolibrary.org/obo/EUPATH_0011473,Urine sample collection process,6e. Was (10-15 ml) laiquot of L/M urine stored with preservative? | 5e. Was (10-15 ml) aliquot of L/M urine stored with preservative?,1=Yes; 2=No; 9=Missing,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036351,Urine collection comment,ext_lab_bv_speclog_iu_st::comment,6,ext_lab_bv_speclog_iu_st,Comment,Sample,http://purl.obolibrary.org/obo/EUPATH_0011473,Urine sample collection process,,,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036109,L:M solution volume,ext_bv_f40::f40q | ext_bv_flm::flmq | ext_bv_f104::f104q,1,ext_bv_flm | ext_bv_f104 | ext_bv_f40,"Participants were given a standard solution with 250 mg/mL lactulose and 50 mg/ml mannitol at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,5a.  Quantity of L/M solution administered in ml (2ml / Kg) | 6a.  Quantity of L/M solution administered in ml (2ml / Kg),99 = missing,variable,,,,PROVIDE Randomized Controlled Trial,,mL,http://purl.obolibrary.org/obo/UO_0000098,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036402,L:M excretion ratio,ext_mgmt_bv_lmratio::lmratio,10,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,Urinary Lactulose:Mannitol ratio. Derived  Recovery of lactulose [LRECV] ‚àö√± Recovery of Mannitol [MRECV],,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011215,Lactulose dosage,ext_mgmt_bv_lmratio::lintake,2,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks. Participants were given a standard solution with 250 mg/mL lactulose and 50 mg/ml mannitol.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,Intake of Lactulose mg/ml,,variable,,,,PROVIDE Randomized Controlled Trial,,mg,http://purl.obolibrary.org/obo/UO_0000022,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036397,Lactulose excreted,ext_mgmt_bv_lmratio::lurin,3,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,Lactulose excreted mg/L. Pulled from LAB_BV_LM_Lactulose_Mannitol Lab,#NAME?,variable,,,,PROVIDE Randomized Controlled Trial,,mg/L,http://purl.obolibrary.org/obo/UO_0000273,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036399,Total lactulose excreted,ext_mgmt_bv_lmratio::lexcret,4,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,"Total Lactulose excreted. Lactulose result (LURIN) x 10 x total urine collected in L (URINML/1000) (Machine reads are  mg% or mg/100mL, converted to mg/L by multipling by 10)",,variable,,,,PROVIDE Randomized Controlled Trial,,mg,http://purl.obolibrary.org/obo/UO_0000022,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036401,Lactulose excreted (%),ext_mgmt_bv_lmratio::ulrecv,5,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,Urinary Lactulose Recovery %. Lactulose excreted (mg) [LEXCRET] ‚àö√± Lactulose intake [LINTAK],,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011216,Mannitol dosage,ext_mgmt_bv_lmratio::mintake,6,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks. Participants were given a standard solution with 250 mg/mL lactulose and 50 mg/ml mannitol.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,Intake of Mannitol mg/ml,,variable,,,,PROVIDE Randomized Controlled Trial,,mg,http://purl.obolibrary.org/obo/UO_0000022,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036398,Mannitol excreted,ext_mgmt_bv_lmratio::murin,7,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,Mannitol excreted mg/L. Pulled from LAB_BV_LM_Lactulose_Mannitol Lab,,variable,,,,PROVIDE Randomized Controlled Trial,,mg/L,http://purl.obolibrary.org/obo/UO_0000273,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036400,Total mannitol excreted,ext_mgmt_bv_lmratio::mexcret,8,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,"Total Mannitol excreted. mannitol result (MURIN) x 10 x total urine collected in L  (URINML/1000) (Machine reads are  mg% or mg/100mL, converted to mg/L by multipling by 10)",,variable,,,,PROVIDE Randomized Controlled Trial,,mg,http://purl.obolibrary.org/obo/UO_0000022,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036403,Mannitol excreted (%),ext_mgmt_bv_lmratio::umrecv,9,ext_mgmt_bv_lmratio,"Assessed at 12, 24, 40, and 104 weeks.",Sample,http://purl.obolibrary.org/obo/EUPATH_0011797,Urine test,Urinary Mannitol Recovery %. Mannitol excreted (mg) [MEXCRET] ‚àö√± Mannitol  intake [MINTAK],,variable,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036029,Cytomegalovirus in blood,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036031,Virus in blood,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011985,Astrovirus in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011959,Virus in stool,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036004,Enterovirus in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011959,Virus in stool,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011980,Norovirus in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011959,Virus in stool,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0011982,Rotavirus in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011959,Virus in stool,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0015713,Sapovirus in stool,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0011959,Virus in stool,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,
http://purl.obolibrary.org/obo/EUPATH_0036491,Enterovirus in stool aggregate data,,,,,Sample,http://purl.obolibrary.org/obo/EUPATH_0036028,Virus in stool detection aggregate data,,,category,,,,PROVIDE Randomized Controlled Trial,,,,,,,,,